Application of polymersomes in membrane protein study and drug discovery: Progress, strategies, and perspectives

✅ 全文

聚合物体在膜蛋白研究与药物发现中的应用:进展、策略与展望

作者 Chih Hung Lo; Jialiu Zeng 期刊 Bioengineering & Translational Medicine 发表日期 2022 ISSN 2380-6761 DOI 10.1002/btm2.10350 类型 原创研究 (Original Research)

📄 中文摘要 Chinese Abstract

中文
膜蛋白(MPs)在细胞信号传导中至关重要,是主要的药物靶点,但由于其在天然脂质环境之外的不稳定性,其研究面临巨大挑战。聚合物囊泡——由自组装嵌段共聚物形成的纳米囊泡——为膜蛋白的重组提供了一种稳定且可调的脂质体替代方案。本综述探讨了利用聚合物囊泡作为膜模拟物研究膜蛋白结构与功能的最新进展,重点关注重组策略、生物物理表征以及在药物发现中的应用,特别是高通量筛选(HTS)。

📋 英文结构化总结 English Structured Summary

全文整理

EN

Background:

Membrane proteins (MPs) are essential for cellular signaling and represent major pharmaceutical targets, yet their study is challenging due to instability outside native lipid environments. Polymersomes—nanovesicles formed from self-assembling block copolymers—offer a stable, tunable alternative to liposomes for MP reconstitution. This review examines advances in using polymersomes as membrane mimetics to study MP structure and function, with emphasis on reconstitution strategies, biophysical characterization, and applications in drug discovery, particularly high-throughput screening (HTS).

Methods:

The paper reviews methodologies for synthesizing and characterizing polymersomes, including solvent displacement, film rehydration, electroformation, and microfluidic techniques. MP insertion into polymersomes is achieved via three primary strategies: detergent-mediated reconstitution of cell-expressed MPs, cell-free co-translational incorporation, and vesicle destabilization. Characterization employs dynamic and static light scattering, cryo-TEM, AFM, and functional assays such as stopped-flow light scattering, fluorescence spectroscopy, and surface plasmon resonance (SPR).

Results:

Polymersomes successfully reconstitute diverse MPs—including OmpF, aquaporins (AQPZ, AQP0), FhuA, gramicidin A, and Complex I—with preserved structural integrity and functionality. For example, AQPZ-proteopolymersomes exhibit 90-fold higher water permeability than empty vesicles, while OmpF reconstitution enables antibiotic transport assays. Cell-free co-translational incorporation improves folding efficiency and avoids cytotoxicity, and hybrid polymer-lipid systems mitigate hydrophobic mismatch. Proteopolymersomes also support HTS-compatible formats for identifying MP modulators.

Data Summary:

Key quantitative findings include: AQPZ proteopolymersomes showing water permeability of 4680 μm/s; OmpF-S-S-CF insertion confirmed by increased diffusion time in fluorescence correlation spectroscopy; AQP0 proteopolymersomes achieving 189.7 ± 61.3 μm/s water permeability; and FhuA Δ1-159 Ext enabling TMB uptake kinetics via encapsulated HRS. Polymersome membranes range from 5–50 nm in thickness, with sizes typically between 20–100 nm, and demonstrate superior stability over liposomes.

Conclusions:

Polymersomes provide a robust, versatile platform for functional and structural studies of MPs under near-physiological conditions. Their chemical tunability, mechanical stability, and compatibility with both cell-based and cell-free expression systems make them ideal for reconstituting complex MPs. Furthermore, proteopolymersomes show strong potential for integration into drug discovery pipelines, especially in HTS assays targeting membrane receptors and transporters.

Practical Significance:

Proteopolymersomes enable reliable in vitro modeling of MP behavior, facilitating target validation and modulator screening in pharmaceutical research. Their application extends to biosensors, artificial cells, and water purification technologies—such as AQPZ-immobilized membranes achieving >50% salt rejection—demonstrating translational value across biotechnology and medicine.

📋 中文结构化总结 Chinese Structured Summary

中文

背景:

膜蛋白(MPs)在细胞信号传导中至关重要,是主要的药物靶点,但由于其在天然脂质环境之外的不稳定性,其研究面临巨大挑战。聚合物囊泡——由自组装嵌段共聚物形成的纳米囊泡——为膜蛋白的重组提供了一种稳定且可调的脂质体替代方案。本综述探讨了利用聚合物囊泡作为膜模拟物研究膜蛋白结构与功能的最新进展,重点关注重组策略、生物物理表征以及在药物发现中的应用,特别是高通量筛选(HTS)。

方法:

本文综述了聚合物囊泡的合成与表征方法,包括溶剂置换法、薄膜再水化法、电形成法和微流控技术。膜蛋白向聚合物囊泡中的插入主要通过三种策略实现:去垢剂介导的细胞表达膜蛋白重组、无细胞共翻译掺入以及囊泡去稳定化。表征手段包括动态和静态光散射、冷冻透射电子显微镜(cryo-TEM)、原子力显微镜(AFM),以及功能测定如停流光散射、荧光光谱和表面等离子共振(SPR)。

结果:

聚合物囊泡成功重组了多种膜蛋白——包括OmpF、水通道蛋白(AQPZ、AQP0)、FhuA、短杆菌肽A和复合物I——并保持了其结构完整性和功能性。例如,AQPZ-蛋白聚合物囊泡表现出比空囊泡高90倍的水渗透性,而OmpF的重组使抗生素转运测定成为可能。无细胞共翻译掺入提高了折叠效率并避免了细胞毒性,而杂合聚合物-脂质系统缓解了疏水性错配问题。蛋白聚合物囊泡还支持与高通量筛选兼容的格式,用于鉴定膜蛋白调节剂。

数据总结:

关键定量结果包括:AQPZ蛋白聚合物囊泡的水渗透性达到4680 μm/s;OmpF-S-S-CF的插入通过荧光相关光谱中扩散时间的增加得到证实;AQP0蛋白聚合物囊泡的水渗透性达到189.7 ± 61.3 μm/s;FhuA Δ1-159 Ext通过包封的HRS实现了TMB摄取动力学。聚合物囊泡膜厚度范围为5–50 nm,粒径通常在20–100 nm之间,且表现出优于脂质体的稳定性。

结论:

聚合物囊泡为在接近生理条件下对膜蛋白进行功能性和结构性研究提供了一个稳健且多功能的平台。其化学可调性、机械稳定性以及与基于细胞和无细胞表达系统的兼容性,使其成为重组复杂膜蛋白的理想选择。此外,蛋白聚合物囊泡在药物发现流程中展现出强大的整合潜力,特别是在针对膜受体和转运蛋白的高通量筛选测定中。

实际意义:

蛋白聚合物囊泡能够实现对膜蛋白行为的可靠体外建模,促进药物研究中的靶点验证和调节剂筛选。其应用还延伸至生物传感器、人工细胞和水净化技术——例如固定化AQPZ的膜实现了超过50%的盐截留率——展示了其在生物技术和医学领域的转化价值。

📖 英文全文 English Full Text

EN

3332 btm Bioengineering & Translational Medicine Bioeng Transl Med Wiley PMC9842050 9842050 9842050 36684106 10.1002/btm2.10350 Application of polymersomes in membrane protein study and drug discovery: Progress, strategies, and perspectives Lo Chih Hung 1 2 ✉ Zeng Jialiu 1 3 4 ✉ 1 Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore 2 Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA 3 Department of Biomedical Engineering, Boston University, Boston, Massachusetts, USA 4 Department of Chemistry, Boston University, Boston, Massachusetts, USA *

Correspondence , Chih Hung Lo and Jialiu Zeng, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Email: chihhung.lo@ntu.edu.sg and jialiu.zeng@ntu.edu.sg

✉ Corresponding author. 28 6 2022 8 1 e10350 e10350 19 1 2023 © 2022 The Authors. Bioengineering & Translational Medicine published by Wiley Periodicals LLC on behalf of American Institute of Chemical Engineers. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Abstract Membrane proteins (MPs) play key roles in cellular signaling pathways and are responsible for intercellular and intracellular interactions. Dysfunctional MPs are directly related to the pathogenesis of various diseases, and they have been exploited as one of the most sought‐after targets in the pharmaceutical industry. However, working with MPs is difficult given that their amphiphilic nature requires protection from biological membrane or membrane mimetics. Polymersomes are bilayered nano‐vesicles made of self‐assembled block copolymers that have been widely used as cell membrane mimetics for MP reconstitution and in engineering of artificial cells. This review highlights the prevailing trend in the application of polymersomes in MP study and drug discovery. We begin with a review on the techniques for synthesis and characterization of polymersomes as well as methods of MP insertion to form proteopolymersomes. Next, we review the structural and functional analysis of the different types of MPs reconstituted in polymersomes, including membrane transport proteins, MP complexes, and membrane receptors. We then summarize the factors affecting reconstitution efficiency and the quality of reconstituted MPs for structural and functional studies. Additionally, we discuss the potential in using proteopolymersomes as platforms for high‐throughput screening (HTS) in drug discovery to identify modulators of MPs. We conclude by providing future perspectives and recommendations on advancing the study of MPs and drug development using proteopolymersomes. Keywords: biophysical characterization, drug discovery, high‐throughput screening, incorporation, liposome, nano‐vesicle, polymersome, proteoliposome, proteopolymersome, reconstitution status released display-pdf yes is-olf no is-manuscript no is-preprint no is-journal-matter no is-scanned no is-retracted no Revised 2022 May 8; Received 2022 Feb 22; Accepted 2022 May 10; Collection date 2023 Jan. 1. INTRODUCTION Membrane proteins (MPs) constitute 20%–30% of all proteins encoded by the genome of various organisms 1 , 2 , 3 and represent the targets of most pharmacological agents. 4 , 5 , 6 MPs include signal transducers, channel proteins, metabolite transporters, cell surface receptors, enzymes, and anchors. Dysfunctional MPs are associated with various diseases including cancers, autoimmune diseases, and neurological disorders. 7 Therefore, understanding both the structural and functional effects of MPs is of great importance. Currently, 6.5% of the over 181,969 entries of protein structures in the Protein Data Bank are MPs with structures deposited in different databases. 3 , 8 , 9 Of these, only less than 2% have high‐resolution structures consistently found in all databases. 6 , 10 The dearth of studies that focus on MPs can be contributed by various factors. First, MPs are usually unstable and require a bilayer membrane for them to be folded correctly during protein translation. Second, it is difficult to obtain stable and functional MPs of interest in high yields, as MPs are usually low in numbers and tend to aggregate in the cytoplasm, despite attempts at protein overexpression. 6 , 11 Importantly, MPs are generally insoluble in aqueous solution due to the incompatibility between the hydrophobic nature of MP surfaces associated with lipid membranes and the hydrophilicity of solvent molecules. The use of amphiphilic agents is thus necessary to extract MPs from the native membranes and maintain them in a stable soluble form. Hence, there is a need to develop synthetic membrane platforms that mimic native biological membrane to provide amphiphilic environments for the MPs and maintain their structural and functional integrity for in vitro protein studies. 12 , 13 , 14 , 15 Conventional methods of MP study include the usage of protein tethered lipid bilayer and supported planar lipid bilayer membranes. 16 , 17 However, these systems have limitations such as incompatibility between tethered molecules and extra‐membranous domains, inaccessibility of region occupied by tethered molecules as well as uncontrollable orientation of inserted MPs and constraints on their biological functions. 16 , 17 Therefore, cell membrane mimetics with vesicular morphologies known as nano‐vesicles have been increasingly used to overcome these limitations. 18 While liposomes are composed of natural nontoxic phospholipids, polymersomes are formed by amphiphilic block copolymers. 19 , 20 Both types of nano‐vesicles are analogous to biological membrane and suitable for MP residence. 17 , 18 , 20 , 21 , 22 These nano‐vesicles, or small unilamellar vesicles (SUV), have a size of 20–100 nm and have the lowest interfacial area and highest configurational entropy as compared to other morphologies. This makes them more energetically favorable for MP reconstitution. 20 They also have an increased stability over large unilamellar vesicles (LUVs, >100 nm in size) and giant unilamellar vesicles (GUVs, >1 μm in size). 20 Additionally, they contain a concentration gradient, which can play a key role in determining the functions of pore‐forming channel MPs. 23 While liposomes have been widely used and reviewed for their use in MP reconstitution and the related structural and functional studies, 17 they are limited by low stability. 22 To overcome this limitation, polymersomes have been increasingly adopted for MP studies because of their superior stability. 22 , 23 , 24 Liposomes and polymersomes with reconstituted MPs are termed as proteoliposomes and proteopolymersomes, respectively. Apart from finding a suitable membrane support, it is crucial to ensure that the inserted MPs are folded in the correct orientation and maintain their biological functions, in order to facilitate further characterizations of these MPs. 14 , 15 Hence, it is imperative to optimize chemical constituents used in the formation of polymersomes or hybrid polymer‐lipid systems, 25 , 26 , 27 , 28 , 29 , 30 MP production methods, and parameters used in the reconstitution process. 17 , 31 , 32 The reconstitution process plays a key role in determining the efficiency of reconstitution, the quality of the inserted MPs, as well as the resolution and capacity of the methods used to study these MPs. 17 , 31 In this article, we will review the use of polymersomes in MP structural and functional studies, as well as their translational application in high‐throughput screening (HTS) for drug discovery (Figure  1 ). We start by introducing the synthesis and characterization of polymersomes and methods of MP reconstitution to form proteopolymersomes. We then summarize the use of proteopolymersomes in studying both the structures and functions of channel proteins, MP complexes, and membrane receptors. Additionally, we provide a comprehensive list of factors affecting the efficiency of MP insertion and the quality of the inserted MPs. Finally, we discuss the feasibility and current applications of proteo‐nano‐vesicles in HTS. We conclude by providing future prospects in using polymersomes to engineer artificial cells as well as laying out a roadmap with recommendations for using proteopolymersomes in drug discovery pipeline. FIGURE 1 Polymersomes as platforms for MP study and drug discovery. Polymersomes, which are made up of block copolymers, can mimic biological membranes for reconstitution or incorporation of MPs, including channels, receptors, and protein complexes to form proteopolymersomes (center). Proteopolymersomes can be used to study the structure–function relationship of MPs including the characterization of (a) receptor‐ligand binding through the use of surface plasmon resonance (SPR), 33 (b) channel transport function through conducting fluorescent dye leakage assay, and (c) MP structure by nuclear magnetic resonance (NMR). Source : Figure  1c is reproduced with permission from reference 34 , Copyright 2018, Springer Nature. (d) Proteopolymersomes can also be used in high‐throughput screening (HTS) for drug discovery to identify modulators of MPs. Schematics were created with BioRender.com. 2. SYNTHESIS AND CHARACTERIZATION OF POLYMERSOMES Polymersomes are spherical nanovesicular systems with polymer shells of 5–50 nm in thickness and are formed by the self‐assembly of amphiphilic block copolymers. 35 , 36 , 37 , 38 The polymersome membrane provides a physical barrier that isolates the encapsulated materials from external biological environment, while allowing controlled release or exchange of biological molecules due to the presence of a concentration gradient. A major difference between polymersomes and liposomes lies in the chemical versatility to control the thickness of the membranes where liposomes are limited to a membrane thickness of up to 5 nm, while polymersomes can have membrane thickness of up to 50 nm, depending on the type of block copolymers used. 24 This suggests that polymersomes could potentially accommodate larger and higher amounts of MPs than liposomes, although it is important to consider the hydrophobic mismatch that might be present during MP insertion. 24 Due to the higher molecular weight of constituent block polymers and the potential of forming cross‐linking structures through UV irradiation, 39 , 40 polymersomes usually have enhanced mechanical properties, 41 , 42 higher stability, 43 , 44 lower dissociation rates, lower permeability, 44 and limited leakage 45 compared to liposomes (Figure  2a ). 20 , 22 Furthermore, their dense hydrophilic polymer brush‐like coronas increases their resistance to degradation and have longer circulation half‐lives in vivo. 48 FIGURE 2 Properties of polymersomes and their formation mechanisms and characterization. (a) Comparison of vesicle properties between polymersomes and liposomes. 20 (b) Polymersomes are formed by self‐assembly of block copolymers into a vesicular structure. Various compositions of diblock copolymers (AB) and triblock copolymers (ABA, BAB, and ABC) are used in the formation of polymersomes. Source : Reproduced with permission from reference 46 , Copyright 2012, Elsevier. (c) A list of chemical constituents of diblock and triblock copolymers used in polymersome synthesis. (d,e) Schematics of two different proposed mechanisms for polymersome formation where (d) spherical micelles are first formed from the self‐assembly of block copolymers, which are then further self‐assembled into micelles with cylindrical or disk morphologies that can wrap around to form a vesicular shape; and (e) small spherical micelles are formed from rapid self‐assembly of block copolymers which then grow into larger micelles. Source : Figure  2d,e is modified and reproduced with permission from reference 44 , Copyright 2011, Springer Nature. (f) Cryo‐TEM images of polymeromes formed by PEO‐PBD copolymer. The hydrophobic cores of PBD are the darker areas. Scale bar represents 50 nm. Source : Modified and reproduced with permission from reference 47 , Copyright 2002, ACS Publications. Schematics were created with BioRender.com. 2.1. Types of copolymers used in polymersome synthesis Diblock (AB) and triblock (ABA, BAB, and ABC) copolymers 35 , 36 , 37 , 38 are usually used in polymersome synthesis, with A and C being the hydrophilic blocks and B being the hydrophobic block (Figure  2b,c ). 46 , 47 Control over the polymer block length and the hydrophilic to hydrophobic block ratio allow for tuning of membrane thickness, morphology, rigidity, and permeability of the polymersome. 23 , 37 , 49 , 50 2.1.1. Diblock copolymers The most commonly used diblock polymers is poly(butadiene)‐ b ‐poly(ethylene oxide) (PBD‐PEO)‐based. 47 , 49 , 51 Their ability to provide more fluidity over other diblock copolymers make them suitable for studying membrane receptors. 52 , 53 Polystyrene‐ b ‐poly(isocyanoalanine[2‐thiophen‐3‐yl‐ethyl]amide) (PS‐PIAT) diblock copolymers self‐assemble into an intrinsically porous bilayer, 54 and have been used to overcome the issue of lower permeability in polymersomes, allowing the function of larger channel or pore‐forming proteins to be tested. Other forms of diblock polymers that have been used in MP studies include poly(ethylene glycol)‐ b ‐poly(trimethylene carbonate) (PEG‐PTMC) 55 and poly (methyl acrylate)‐ b ‐poly(ethylene glycol) (PAA‐PEG). 56 2.1.2. Triblock copolymers Poly(2‐methyloxazoline)‐poly(dimethylsiloxane)‐poly(2‐methyloxazoline) (PMOXA‐PDMS‐PMOXA) 57 , 58 is the most commonly used triblock (ABA) polymer in polymersome synthesis for MP studies. ABA polymers can change their conformation to adapt to the MP length to overcome hydrophobic mismatch, as demonstrated in reconstitution of outer membrane porin F (OmpF) protein in PMOXA‐PDMS‐PMOXA 59 and ATP synthase, or bacteriorhodopsin (BR) reconstitution in poly(2‐ethyl‐2‐oxazoline)‐ b ‐poly(dimethylsiloxane)‐ b ‐poly(2‐ethyl‐2‐oxazoline) (PEtOz‐PDMS‐PEtOz). 60 , 61 , 62 To create a polymeric nanocompartment with low permeability, polyisobutylene‐polyethylene glycol‐polyisobutylene (PIB‐PEG‐PIB) (BAB) with the PIB unit being impermeable to many molecules, 63 has been used in the formation of polymersomes with the insertion of an Escherichia coli ( E. coli ) outer MP. 64 Poly(lactic acid)‐poly(ethylene glycol)‐poly(lactic acid) (PLA–PEG–PLA) is another type of BAB polymer, which has been used to synthesize polymersomes as nanocarriers for delivery of hydrophilic and hydrophobic drugs. 65 To account for the membrane asymmetry in lipid composition, poly(ethylene oxide)‐ b ‐poly(dimethylsiloxane)‐ b ‐poly(2‐methyloxazoline) (PEO‐PDMS‐PMOXA) (ABC) is used. 66 , 67 ABC polymers can adopt a mixture of hairpin or transmembrane orientations due to steric hindrance and are useful for MP study as they can change their chemical composition to influence the orientation of the inserted integral proteins upon the application of external fields such as electric fields to its membrane leaflets. 68 Recently, an one‐pot synthesis method of a new ABC triblock terpolymer, poly(ethylene oxide)‐ block ‐poly(2‐(3‐ethylheptyl)‐2‐oxazoline)‐ block ‐poly(2‐ethyl‐2‐oxazoline) (PEO‐PEHOx‐PEtOz), using sequential microwave‐assisted polymerization has been reported. 69 The asymmetry of the formed polymersomes can be adjusted by varying the ratio of PEO to PEtOz and potentially be used for directed insertion of MPs. In another study, poly(ethylene glycol)‐poly(diisopropylaminoethyl methacrylate)‐ b ‐poly(styrenesulfonate) (PEG‐PDPA‐PSS) has been used for directed insertion of proteorhodopsin (PR). 70 Other types of ABC polymers, including poly(ethylene oxide)‐ b ‐polycaprolactone‐ b ‐poly(2‐methyl‐2‐oxazoline) (PEO‐PCL‐PMOXA) 71 and PAA‐PMA‐PEG 56 have also demonstrated success in forming polymersomes and may offer new avenues for MPs study in novel applications. 2.2. Synthesis of polymersomes There are two different proposed mechanisms for the formation of polymersomes where (i) spherical micelles are first formed from the self‐assembly of block copolymers, which are then further self‐assembled into micelles with cylindrical or disk morphologies that can wrap around to form a vesicular shape (Figure  2d ); and (ii) small spherical micelles are formed from rapid self‐assembly of block copolymers, which then grow into larger micelles and polymersomes (Figure  2e ). 72 Specifically, polymersomes can be synthesized from different copolymers via solvent‐displacement, polymer film rehydration, solid rehydration, or electroformation techniques. 43 , 67 , 73 In solvent displacement method, the polymer is dissolved in a suitable organic solvent and added dropwise to an aqueous buffer and stirred vigorously to form an emulsion. While being a simple and fast method, the polydispersity of polymersome sizes is high, 74 and residual organic solvents may denature most amphiphilic MPs and result in low reconstitution efficiency. 75 To overcome the use of organic solvents, polymer rehydration technique has been developed, where the polymer solution is first dried to remove traces of organic solvents before rehydration in aqueous buffers. Polyethyleneoxide‐polyethylethylene (PEO‐PEE)‐based polymersomes generated using the polymer film rehydration method yields small polymersomes with a size of about 100 nm but with a broad size distribution. 45 In solid rehydration, the polymer is made into bulk powder form before rehydration in aqueous buffers. However, it requires stronger and longer agitation time for complete rehydration. 45 Electroformation is another method commonly used to synthesize PMOXA‐PDMS‐PMOXA and PB‐PEO polymersomes, 76 , 77 but this method results in polymersomes in a larger size range of 10–40 μm. 78 Other techniques include 3D soft‐confined solvent annealing, 79 droplet microfluidic that have been used to produce PEG–PLA‐based polymersomes, 80 and gel‐assisted rehydration where polymer solutions are spread across dehydrated agarose films and subsequently rehydrated in aqueous buffers. 81 2.3. Characterization of polymersomes The hydrodynamic radius, size distribution, and morphology of the formed polymersomes can be characterized by dynamic light scattering (DLS), static light scattering (SLS), optical microscopy, and transmission electron microscopy (TEM). 82 High‐throughput scattering methods such as combinatorial small‐angle X‐ray scattering (SAXS) or wide‐angle x‐ray scattering (WAXS) can provide information about structural features of colloidal size, including membrane bilayer thickness and internal structure. 83 The small‐angle neutron scattering (SANS) technique can study the morphology and thermodynamics of polymer blends and copolymers in polymersomes, as well as the polymersome structure. 84 Optical microscopy can only resolve polymersomes larger than 1 μm in diameter, 85 while higher resolution imaging tools such as TEM, cryo‐TEM, and freeze fracture cryo‐scanning electron microscopy (FF‐Cryo‐SEM) are able to give about a 1000‐fold increase in resolution and a 100‐fold increase in depth of field. 85 In particular, cryo‐TEM can avoid the drying process associated artifacts in electron microscopy sample preparation and can provide the information regarding the size, morphology, and bilayer thickness of polymersomes (Figure  2f ). 83 Atomic force microscopy (AFM) can also be used to characterize the mechanical properties of polymersomes. 83 3. STRATEGIES FOR MP INSERTION TO FORM PROTEOPOLYMERSOMES The reconstitution or insertion of MPs in polymersomes has emerged as a powerful tool in studying the structure and functionality of MPs. 86 To retain the structural integrity of MPs and confer their biological functionalities, MPs have to be preserved in amphiphilic environment similar to their native environment such as the use of detergents to prevent denaturation. The protein–detergent–membrane interaction play a key role in MP insertion, which is affected by the different methods of protein production and purification, the type and amount of detergents used, and the different physicochemical properties of polymersomes, including their fluidity and flexibility. MPs can be reconstituted via three major methods: (1) cell‐based protein production and detergent mediated reconstitution, 87 (2) cell‐free co‐translational protein production and direct incorporation, 53 and (3) reconstitution by destabilization of vesicles or supported planar bilayer membranes. 88 , 89 , 90 , 91 , 92 , 93 Following reconstitution, purification steps such as dialysis, gel filtration or size exclusion chromatography (SEC), centrifugation, and bio‐beads aided procedures should be carried out to remove excess detergents and other reagents to enhance the formation of stable proteopolymersomes. 3.1. Cell‐based protein production and detergent mediated reconstitution The recombinant MPs are first purified from plasmid transformed bacteria cultures, and the purified MPs are solubilized with detergents and emulsified with excess polymers via self‐assembly, followed by detergent removal (Figure  3a ). 32 , 94 The addition of detergents allows for ease of MPs solubilization and keeps them in a native environment to facilitate MPs folding and stabilization. Upon protein reconstitution, the detergent molecules need to be removed to aid in the formation of stable vesicles, and residual detergent may also inhibit protein activity. 94 Multiple MPs have been reconstituted into polymersomes through this approach with common detergent removal methods including dialysis, 95 gel filtration or SEC, 86 , 87 centrifugation, 52 or bio‐beads aided procedures (Table  1 ). 86 , 87 In the dialysis method, the MPs and polymersome emulsion are dialyzed against a larger volume of buffer to remove the excess detergents. 95 For gel filtration or SEC‐mediated detergent removal, the MP‐polymersome solution is passed through a gel‐exclusion column which separate and elute the proteopolymersomes before the detergent. Different sized columns can be used ranging from Sephadex G25 to G200. 94 This technique has the advantage of being rapid but can lead to a broader size distribution in proteopolymersomes. Using the centrifugation approach, the excess detergents as well as free MPs are filtered through centrifugal filtration cartridges of a certain molecular weight cut‐off. 90 For bio‐beads mediated detergent removal, the beads are used to physically adsorb and sequester excess detergents, where the detergent‐bound beads can subsequently be removed by centrifugation or filtration. 94 The choice of detergent removal method and its efficiency are dependent on the type of detergent used during the MP reconstitution process. 94 , 114 Detergents with a high critical micelle concentration (CMC), such as cholate and octyl glucoside, tend to form smaller micelles and make them easier to remove via the process of dialysis or by SEC. 94 , 114 Detergents with a lower CMC, such as Triton‐X 100 which forms larger micelles, are less likely to be removed by dialysis or SEC and hence are more often removed via bio‐beads aided process. 94 , 114 Some limitations associated with cell‐based protein production or MP overexpression are low yield, cell cytotoxicity, protein aggregation, and misfolding, which can in turn result in polymer membrane overcrowding. 115 FIGURE 3 MP insertion strategies to form proteopolymersomes. (a) Detergent‐mediated reconstitution of MPs into polymersomes. MPs from native membranes are purified, solubilized, and stabilized by detergents. The MP solution is then mixed with polymers dissolved in organic solvent to form an emulsification with a mixture of polymer–protein–detergent micelles. When detergent is removed from the micellar solutions via procedures such as dialysis, gel filtration/SEC, centrifugation or with the use of bio‐beads, MPs are reconstituted into vesicles forming proteopolymersomes. Source : Modified and reproduced with permission from reference 87 , Copyright 2002, SciELO. (b) Spontaneous incorporation of MPs into polymersome to form proteopolymersomes through cell‐free protein synthesis by adding complementary DNA encoding the protein of interest and polymersomes directly to an in vitro expression mixture, including RNA polymerase and ribosome. Source : Modified and reproduced with permission from reference 53 , Copyright 2012, John Wiley and Sons. (c–e) Vesicle destabilization by detergents in (c) liposome with reconstitution of NorA multidrug efflux transporter as an example, 88 (d) hybrid vesicle made of lipids and polymers with reconstitution of Cyt‐bo3 ubiquinol oxidase as an example, 89 and (e) polymersome with enhanced orientation and improved functionality of NADH:ubiquinone oxidoreductase (Complex I) as an example. 90 (f) Destabilization of supported planar polymer bilayer membrane by bio‐beads for MP reconstitution with functional insertion of M1oK1 as an example. Source : Modified and reproduced with permission from reference 91 , Copyright 2014, Elsevier. Schematics were created with BioRender.com. TABLE 1 List of proteopolymersomes based membrane protein studies Membrane transport proteins Block copolymers Protein production Insertion method; purification method (A) Proteopolymersome characterization References (B) MP structural studies (C) MP functional studies Outer membrane protein F (OmpF) PMOXA–PDMS–PMOXA Cell based Detergent mediated; gel filtration/SEC (A) Cryo‐TEM, DLS, SLS, TEM, AFM 26 , 96 , 97 (B) N/A (C) Iodometry to monitor ampicillin hydrolysis by β‐lactamase; LSM OmpF 6His PMOXA–PDMS–PMOXA Cell based Detergent mediated; gel filtration/SEC (A) DLS 98 (B) CD (C) Leakage assay of fluorescent dye OmpF‐S‐S‐CF PMOXA 6 –PDMS 44 –PMOXA 6 Cell based Detergent mediated; dialysis (A) SLS, DLS, Cryo‐TEM 99 (B) N/A (C) Fluorescence generated when using AmR as a substrate for HRP, FCS, EPR Aquaporins (AQPs) PMOXA 11 –PDMS 34 Cell based Detergent mediated; dialysis (A) DLS 95 (B) N/A (C) SFLS, DLS AQPZ PMOXA 15 –PDMS 110 –PMOXA 15 Cell based Detergent mediated; bio‐beads (A) DLS, FETEM 100 (B) N/A (C) SFLS AQP0 PEO 14 –PB 22 , PEO 14 –PB 22 , PMOXA 20 –PDMS 42 –PMOXA 20 PMOXA 12 –PDMS 55 –PMOXA 12 Cell based Detergent mediated; gel filtration/SEC or Dialysis (A) EM, RS 101 , 102 (B) N/A (C) SFLS Ferric hydroxamate uptake protein component A (FhuA) FhuA Δ1–129 FhuA Δ1–160 PMOXA–PDMS–PMOXA Cell based Detergent mediated; bio‐beads or dialysis (A) ITC, DLS 27 , 103 (B) CD (C) FCS FhuA Δ1–159 PIB 1000 –PEG 6000 –PIB 1000 Cell based Detergent mediated; gel filtration/SEC (A) DLS, Cryo‐TEM 64 (B) CD (C) Absorbance detection at 370 nm of TMB oxidation product when using TMB as a substrate for encapsulated HRP Gramicidin A (gA) PMOXA–PDMS–PMOXA Cell based Detergent mediated; gel filtration/SEC (A) TEM, SLS 104 (B) N/A (C) SFLS; Fluorescence spectroscopy on changes of the ANG‐2 dye specific for Na + transport and APG‐2 dye specific for K + transport Ionomycin PMOXA 6 –PDMS 44 –PMOXA 6 Cell based Detergent mediated; gel filtration/SEC (A) TEM 105 (B) N/A (C) SFLS; Fluorescence spectroscopy on changes in the calcium sensitive ACG dye due to influx of Ca 2+ ions KcsA PMOXA–PDMS–PMOXA Cell based Detergent mediated; dialysis (A) FCS 59 (B) Z‐scan fluorescence correlation spectroscopy (C) N/A Maltoporin (LamB) PMOXA–PDMS–PMOXA Cell based Detergent mediated; gel filtration/SEC (A) Langmuir trough 28 (B) N/A (C) Fluorescence spectroscopy monitoring the change in fluorescently labeled DNA released into the vesicle Nucleoside‐specific porin (TsX) PMOXA 20 –PDMS 54 PMOXA 20 Cell based Detergent mediated; gel filtration/SEC (A) DLS, Gel electrophoresis 106 (B) N/A (C) Fluorescence due to hydrolysis of prodrug 2‐fluoroadenosine to 2‐fluoroadenine Large conductance mechano‐sensitive ion channel (MscL) Hybrid vesicles: (a) 1,2‐dioleoyl‐sn‐glycero‐3‐phosphocholine (DOPC) (b) PEO 9 ‐b‐PBD 12 ; PEO 14 ‐b‐PBD 22 ; PEO 24 ‐b‐PBD 36 Cell free Co‐translational incorporation; gel filtration/SEC (A) Western blotting 51 (B) mEGFP fluorescence due to proper folding (C) Leakage assay of fluorescent dye α‐Hemolysin PBD‐PEO Cell free Co‐translational incorporation; centrifugation (A) SEM 52 (B) N/A (C) Leakage assay of fluorescent dye NADH: ubiquinone oxidoreductase (Complex I) PMOXA (9–64) –PDMS (23–165) –PMOXA (9–64) Cell based Detergent mediated with vesicle destabilization; bio‐beads (A) EPR, BCA 90 (B) N/A (C) NADH/Ferricyanide or NADH/Decylubiquinone or NADH:Ubiquinone 2/AQ oxido‐reductase activity assay; Complex I inhibition assay F o F 1 ‐ATPase and BR PEtOz−PDMS−PEtOz Cell based Detergent mediated; dialysis (A) TEM 61 , 62 , 107 (B) N/A (C) Production of photoinduced electrochemical proton gradient; ATP synthesis activity Proteorhodopsin (PR) PEG–PDPA–PSS Cell based Detergent mediated; centrifugation (A) TEM 70 (B) PR would orientate with negatively charged PSS (C) Light‐activated pH changes Proteorhodopsin (PR) PS‐ b ‐P4MVP 2 Cell based Detergent mediated; centrifugation (A) TEM 108 (B) SAXS, RS, ssNMR (C) Time‐resolved visible spectroscopy (flash photolysis) Cytochrome bo3 (Cyt‐bo3) Hybrid vesicles: (a) PBd 22 ‐ b ‐PEO 14, (b) POPC Cell based Detergent mediated or vesicle destabilization; bio‐beads (A) DLS and TEM 89 (B) N/A (C) Decylubiquinone oxidation reaction initial rate NaAtm1 P‐glycoprotein (PgP) Hybrid vesicles: (a) Palmitoyl‐oleoyl‐phosphatidylcholine, (b) PBD‐PEO Cell based Detergent mediated; bio‐beads (A) Flotation in a sucrose density gradient 30 (B) N/A (C) Passive permeability to a fluorescent probe Membrane receptors Block copolymers Protein production Insertion method; purification method (A) Proteopolymersome characterization References (B) MP structural studies (C) MP functional studies Dopamine receptor D2 (DRD2) PBD–PEO PMOXA–PDMS–PMOXA Cell free Co‐translational incorporation; centrifugation (A) Western blotting 53 (B) Conformational antibody binding (SPR) (C) Native ligand binding and replacement assay (compete dye‐labeled ligand with unlabeled ligand) C‐X‐C chemokine receptor type 4 (CXCR4) PB–PEO Cell free Co‐translational incorporation; centrifugation (A) Western blotting 109 (B) Conformational antibody binding (SPR) (C) Native ligand binding Glucagon‐like peptide‐1 receptor (GLP‐1R) PBD–PEO PMOXA–PDMS–PMOXA Cell free Co‐translational incorporation; dialysis (A) Western blotting, TEM, DLS, SEC 110 (B) Conformational antibody binding (SPR) (C) Native ligand binding, radioligand saturation binding assay Claudin‐2 (Cldn‐2) PBD–PEO Cell free Co‐translational incorporation; centrifugation (A) SEM, Western blotting 52 (B) Conformation antibody binding (SPR) (C) N/A Major histocompatibility complex I (MHC‐I) PMOXA–PDMS–PMOXA Cell free Co‐translational incorporation; bio‐beads (A) Fluorescent microscopy images of antibody binding 111 (B) Conformational antibody binding (SPR) (C) T‐cell activation Peptide anchors PMOXA–PDMS–PMOXA Cell based Detergent mediated; gel filtration/SEC (A) SEC, confocal microscopy, tryptophan fluorescence measurements 112 , 113 (B) Intact with membrane (nonpore forming), CD (C) N/A Abbreviations: ACG, Asante Calcium Green; AFM, atomic force microscopy; AmR, Amplex UltraRed; ANG‐2,Asante NaTRIUM Green‐2; APG‐2, Asante Potassium Green‐2; BCA, bicinchoninic acid protein assay; CD, circular dichroism; DLS, dynamic light scattering; EM, electron microscopy; EPR, electron paramagnetic resonance; FCS, fluorescence correlation spectroscopy; FETEM, field emission transmission electron microscopy; HRP, horse radish peroxidase; ITC, isothermal calorimetry; LSM, laser scanning microscopy; RS, Raman spectroscopy; SAXS, small angle x‐ray scattering; SEC, size exclusion chromatography; SFLS, stopped flow light scattering kinetics; SLS, static light scattering; SPR, surface plasmon resonance; ssNMR, solid‐state NMR spectroscopy; TEM, transmission electron microscopy; TMB, 3,3′,5,5′‐tetramethylbenzidine. 3.2. Cell‐free co‐translational protein production and direct incorporation The MP of interest is expressed from a plasmid and directly incorporated into the polymersome (Figure  3b ). 116 In this method, the cDNA coding for the MP of interest and reaction mixtures containing necessary components for protein translation are added to polymersomes in solution and incubated at elevated temperatures for a few hours. A typical reaction mixture is composed of a cell extract from E. coli , wheat germ, or rabbit reticulocytes, containing components such as ribosomes, translation factors, aminoacyl‐tRNA synthetases, and tRNAs, which are required for production of protein. 117 , 118 , 119 A more recent development is cell‐free protein synthesis using recombinant elements (PURE) system, which comprises individually purified components of the E. coli translation apparatus. 120 The PURE system does not contain cell extract and results in less degradation of cDNA template as well as protein products, thereby allowing for more efficient incorporation of MPs. 120 The cell‐free method also allows direct access to reaction conditions, where additional agents which aid the reconstitution process such as detergents or protein folding catalysts can be included. 115 The cell‐free method overcomes the issues associated with conventional overexpression and reconstitution of MPs into membrane models, such as low protein yields, cytotoxicity, misfolding, and aggregation. 121 , 122 Upon reconstitution, the proteopolymersome size and morphology can be further fine‐tuned through freeze–thaw, extrusion, and sonication methods. 94 , 114 Polymersomes without MPs, as well as excess cell‐free expression reaction reagents, can be removed from proteopolymersomes by methods similar to detergent removal including dialysis, 110 gel filtration or SEC, 86 , 87 centrifugation, 53 and bio‐beads mediated process. 111 A limitation of the direct incorporate approach is that the necessary posttranslational modifications, which are required for the formation of fully functional proteins may not occur, unless known enzymes responsible for these processes are added to the reaction mixture. 123 3.3. Reconstitution by destabilization of vesicles or supported planar bilayer membranes Membrane destabilization by detergents has been used to reconstitute MPs in liposomes (Figure  3c ) 88 and hybrid vesicles (Figure  3d ), 89 as wells as a way to enhance the orientation and functionality of reconstituted MPs in polymersomes (Figure  3e ). 90 While the use of detergents and their removal are also necessary in this approach, the key difference lies in the vesicles or proteo‐vesicles being formed first, followed by the addition of detergents to perturb the integrity of the vesicles to allow for solubilized MPs insertion 88 or reorientation of the inserted MPs. 90 Multidrug resistance (MDR) transporter NorA was incorporated in liposomes made from E. coli polar lipid crude extract by destabilization using detergents. 88 Liposome destabilization was achieved by the stepwise addition of Triton X‐100 and mixed with NorA protein solution, and bio‐beads were added for detergent removal. 88 Cytochrome bo3 (Cyt‐bo3) has been incorporated in hybrid vesicles made of PBD‐PEO and POPC using detergent‐mediated reconstitution. Hybrid vesicles are first formed by extrusion and destabilized by gradual addition of small concentrations of Triton X‐100 detergent. At the brink where the detergent started to break up the integrity of the hybrid vesicles, Cyt‐bo3 solutions were added and incorporated into the vesicles, where the excess detergents are then removed by bio‐beads. 89 NADH:ubiquinone oxidoreductase (Complex I) was incorporated in PMOXA‐PDMS‐PMOXA polymers using detergent‐mediated reconstitution. Partial destabilization of the polymer membrane by adding Triton X‐100 detergent allows for rearrangement of the inserted Complex I to enhance its structural orientation with a considerable fraction of vesicles remained intact. 90 Other types of membrane destabilization methods, such as voltage and bio‐beads mediated destabilization, have been used to reconstitute MPs on supported planar lipid or polymer bilayer membranes. Bio‐beads mediated MP insertion has been used for the insertion of MloK1, a cyclic nucleotide‐modulated potassium channel from Mesorhizobium loti, into supported PDMS‐PMOXA‐based polymeric membranes (Figure  3f ). 91 To achieve functional insertion of M1oK1, both the protein and the polymer membrane were destabilized by bio‐beads. The bio‐beads provided the driving force for the insertion of the MP into the polymer membrane. The conductance across M1oK1 increased only when protein reconstitution was carried out in the presence of bio‐beads. 91 Voltage destabilization is another approach that has been suggested with the insertion of α‐hemolysin into supported planar polymer membranes made of PB‐PEO diblock copolymers as an example. 92 , 93 Cell‐based protein production followed by detergent‐mediated reconstitution has been the predominantly used method in MP insertion. The adoption of the cell‐free co‐translational incorporation approach, which overcomes limitations in cell‐based protein production, has been on a rise. The membrane destabilization method is still largely limited to MP reconstitution in liposomes, hybrid vesicles or planar membrane bilayers. Regardless of the methods used, reproducibility and predictability are two important requirements to fulfill in the engineering of proteopolymersomes to allow for accurate acquisition of biological information related to the MPs of interest and their applications such as in engineering of artificial cells and drug discovery. In general, the proteopolymersomes formed should have bilayer thickness that match MP hydrophobic domain, high mechanical strength, good stability, and conformation flexibility to adapt to MP insertion and functionality. 4. MEMBRANE TRANSPORT PROTEINS Membrane transport proteins are MPs that play important roles in maintaining the physiological function of cells. There are two different types of transport (passive and active) across cell membranes. Passive transport requires no energy input as transport follows a concentration gradient and examples include channel proteins. 124 In contrast, active transport requires energy, most commonly from ATP hydrolysis by primary active transporters, which include proton pumps. Active transport is used to carry substances into a cell against the concentration gradient. 125 Liposomes have been used to study membrane transport proteins, in particular channel proteins; however, their highly fluid and leaky nature hinders the retention of molecules, often resulting in inaccurate measurement of these protein functions. 20 , 125 Polymersomes can overcome these issues with their low passive permeability to low‐molecular‐weight solute, 44 and have been used widely by researchers to reconstitute and incorporate channel proteins or porins. 99 Apart from studying the functional activity of channel proteins, the activity of protein complexes can also be modeled and studied with proteopolymersomes. These complexes include primary active transporters and MP coupling systems such as NADH:ubiquinone oxidoreductase (Complex I), F 0 F 1 ‐ATPase, and proton pumps. We have summarized the various types of channel proteins for passive transport and protein complexes for active transport studied in polymersomes (Table  1 ). 4.1. Channel proteins for passive transport 4.1.1. OmpF The outer membrane protein F (OmpF) is a MP that functions as a passive diffusion channel in E. coli and assembles to form a highly stable trimer in membranes. OmpF functions as the main route of outer membrane penetration for many antibiotics, hence studying its structure and function can be of clinical importance in determining bacterial resistance mechanisms and therapeutic advancements. 126 OmpF is the first MP successfully reconstituted with full functionality into PMOXA–PDMS–PMOXA membranes. 25 , 26 , 96 , 97 , 106 The OmpF reconstitution efficiency is increased with homogenous distribution of MPs and polymers coupled with slow controlled removal of surfactants. 26 The successful passage of antibiotics, such as ampicillin, demonstrates the functional reconstitution of OmpF in polymersomes. 25 , 26 OmpF function has also been determined through monitoring the conversion of passaged substrates with no antibacterial activity into substrates with bacterial activity or antibiotics by the encapsulated penicillin acylase enzyme. 97 OmpF containing double mutants (K89C and R270C) with SAMSA fluorescein conjugation through disulfide bonding termed as OmpF‐S‐S‐CF is reconstituted into PMOXA‐PDMS‐PMOXA polymersomes via the rehydration method (Figure  4a ). 99 The successful insertion of OmpF into polymersomes is evaluated using fluorescence correlation spectroscopy (FCS) to determine whether there is an increase in diffusion time (Figure  4b ), 99 or by electron paramagnetic resonance (EPR) which has a broad spectrum, indicative of low mobility due to successful MP reconstitution. The protein functions are determined via encapsulating horse radish peroxidase (HRP) in polymersomes and monitoring for changes in fluorescence due to the formation of resorufin‐like product upon successful diffusion of Amplex UltraRed (AmR), a substrate for HRP. The reconstituted proteopolymersomes show good biocompatibility in a zebrafish embryo model, demonstrating potential use of these polymersomes as cellular implants in living organisms. 99 Other modified OmpF such as OmpF 6His has also been successfully reconstituted in PMOXA–PDMS–PMOXA polymersomes. 98 The structure of the OmpF 6His is determined with circular dichroism (CD) in solution, which indicates that OmpF 6His adopts a β‐barrel stable structure in proteopolymersome. Functional reconstitution of OmpF 6His is determined through measuring a significant release of encapsulated acridine orange outside of the proteopolymersomes when the pH was increased from 5 to 7 across the OmpF, which allows for protons to pass through and result in changes in acridine orange. 98 FIGURE 4 Structural and functional studies of channel proteins with passive diffusion using polymersomes. (a) Schematic of polymersomes with channel proteins reconstituted to allow passage of solutes and selective permeability of ions when the channel proteins are active. Example shown is an OmpF proteopolymersome. (b) Insertion of SAMSA fluorescein (SAMSA‐CF) conjugated OmpF with K89C and R270C double mutations through disulfide bonding (OmpF‐S‐S‐CF) was evaluated with fluorescence correlation spectroscopy. Reconstitution of OmpF‐S‐S‐CF into polymersome (blue) increases protein diffusion time, compared to OmpF‐S‐S‐CF in surfactant (1% octyl‐glucopyranoside/1% OG) (green), and SAMSA‐CF only control (black). Dotted line refers to experimental autocorrelation curves and solid line refers to fitted curve. Source : Figure  3a,b is reproduced with permission from reference 99 , Copyright 2018, Springer Nature. (c) Stopped‐flow light‐scattering experiment to characterize vesicle permeability in aquaporin Z (AqpZ) proteopolymersomes. The initial rise rates are used to calculate the permeability and there is an increase in relative light scattering when AqpZ is reconstituted in the polymersomes. Source : Reproduced with permission from reference 101 , Copyright 2007, National Academy of Sciences, USA. (d) Measurements of Na + influx in ANG‐2 (Na + specific dye) loaded polymersomes before and after reconstitution of gramicidin A (gA). The presence of gA allows for higher influx of Na + ions into the polymersomes, resulting in an increase in fluorescence intensity of the ANG‐2. Source : Reproduced with permission from reference 104 , Copyright 2015, Elsevier 4.1.2. Aquaporins Another widely studied class of channel proteins is the aquaporins (AQPs), which are water channels that can mediate bidirectional, transmembrane water flow in the presence of an osmotic gradient. Its dysfunction is associated with multiple human diseases, such as glaucoma, cancer, epilepsy, and obesity. 127 Several AQPs have been reconstituted into PMOXA‐PDMS copolymer‐based polymersomes via detergent‐mediated reconstitution including AQP1‐5, which are highly specific for water and AQP3, 7, 9, and 10, which mediate glycerol flux. 95 The functionality of reconstituted AQPs as solute transporters of water or glycerol is studied with stopped flow light scattering kinetics, where a hyperosmotic gradient is first imposed across the membrane of the AQP proteopolymersomes, and then a hypertonic gradient is applied. Outflow from the polymersome results in faster shrinking and increase in light scattering, indicating higher water permeability as a result of functional AQP reconstitution. 95 Aquaporin Z (AQPZ), which can maintain water permeability while retaining uncharged solutes (i.e., glucose, glycerol, salt, and urea), is reconstituted in PMOXA‐PDMS‐PMOXA polymersomes, where it shows 90 times higher water permeability than polymersomes without AQPZ insertion, as well as high rejection rates of salt, glycerol, and urea (Figure  4c ). 101 However, AQPZ incorporation has a limiting concentration at a protein‐to‐polymer ratio of 1:50, where a further increase in protein concentration decreases water permeability instead of enhancing it. 101 This limit in ratio could be due to the method of reconstitution used, where a higher detergent concentration used in the AQPZ stock solution can lead to reduced AQPZ reconstitution efficiency. This can be overcome by using slow detergent removal methods or other reconstitution methods. 101 In a similar study, AQPZ is reconstituted into disulfide‐functionalized PMOXA‐PDMS‐PMOXA copolymer via film rehydration technique, and the vesicle shrinkage or permeability is determined to be 4680 μm/s. 100 Further studies show that AQPZ water permeability can be improved when reconstituted in PMOXA‐PDMS‐PMOXA membranes with a larger hydrophobic thickness, due to a decrease in Arrhenius activation energies for water transport across the AQPZ. 128 For structural studies of AQPZ, SAXS has been used to determine AQPZ structure that has been reconstituted in PBD‐PEO polymersomes with different molecular weights. SAXS indicates that AQPZ reconstitution in PB 45 ‐PEO 14 leads to a minor difference in average hydrophobic vesicle wall thickness, which could indicate a dimpling or puckering of polymers close to the incorporated AQPZs. On the other hand, in PB 33 ‐PEO 18 , micelle‐formation tendency is reduced when AQPZ is incorporated. 129 The lens specific water channel aquaporin 0 (AQP0) was reconstituted in PEO‐PB and PMOXA‐PDMS‐PMOXA polymersomes with varying copolymer block lengths, where the proteopolymersome size and morphology are optimized through increasing polymer dissolution and reducing detergent removal rate. 102 The successful incorporation of AQP0 in PEO‐PB and PMOXA‐PDMS‐PMOXA is determined with electron microscopy (EM), and the water permeability of AQP0 determined using stopped flow light scattering measurements showed permeability of 189.7 ± 61.3 μm/s, 102 which is high compared to the measured permeability of other reported polymersomes, such as 2.5 μm/s for poly(ethyl ethylene)‐poly(ethylene oxide) (PEE‐PEO). 130 This could be due to smaller hydrophobic repeat units in the PEO‐PB polymer compared to other polymer‐based polymersomes. 102 Apart from MP studies, AQP incorporated polymersomes also can be applied in industrial water purification processes. For instance, AQPZ reconstituted PMOXA‐PDMS‐PMOXA proteopolymersomes are covalently immobilized onto the surface of a porous ultrafiltration cellulose acetate membrane, followed by in situ surface imprinting polymerization to generate a thin imprinted polymer layer. 101 Forward osmosis and nanofiltration functionality were also tested and determined that AQPZ imprinted membrane had salt rejections above 50% and has a membrane selectivity of water to salt, demonstrating AQPZ facilitated water transport and salt rejection. 131 4.1.3. FhuA Polymersomes have also been used to study transmembrane protein ferric hydroxamate uptake protein component A (FhuA), which is one of the largest β‐barrel channel proteins. In E.coli , FhuA mediates the active transport of ferrichrome‐bound iron and it also acts as the receptor for bacteriophages. Truncated variants of FhuA (FhuA Δ1–129 and FhuA Δ1–160) has been reconstituted in PMOXA‐PDMS‐PMOXA polymersomes using cell‐based reconstitution, and the activity of FhuA has been determined through monitoring the passage of sulforhodamine dye into polymersomes, 27 or release of calcein dye out of the polymersomes via fluorescence spectroscopy. 103 The direction of FhuA Δ1–160 insertion has been determined through measuring endodermic changes using isothermal titration calorimetry (ITC) in PMOXA‐PDMS‐PMOXA polymersomes. 132 In a separate study, FhuA Δ1‐159 has been reconstituted into thick PIB‐PEG‐PIB polymersome membranes. 64 To overcome the problem of hydrophobic mismatch that is seen during insertion of FhuA Δ1‐159, the length of MP can be matched to the thickness of the polymersome by doubling the last five amino acids of each of the 22 β‐sheets before the more regular periplasmatic β‐turns, which can lead to an 1 nm increase to become extended FhuA Δ1‐159 (FhuA Δ1‐159 Ext). 64 The secondary protein structure of reconstituted FhuA Δ1‐159 Ext is determined through CD spectroscopy, which shows β‐barrel folding, indicative of correct folding. The functional activity of FhuA Δ1‐159 Ext is proven via kinetic analysis of 3,3′,5,5′‐tetramethylbenzidine (TMB) uptake by encapsulated HRP. 64 4.1.4. Ion channels Ion channels, such as gramicidin A (gA), 104 ionomycin, 105 and KcsA 59 have also been studied in polymersomes. Ion channel gA, which allows for the transport of protons and monovalent ions, is reconstituted in a series of PMOXA–PDMS–PMOXA polymersomes with membrane thickness ranging from 9.2 to 16.2 nm, where membranes thicker than 12.1 nm did not result in successful reconstitution of gA protein, potentially due to hydrophobic mismatch of the protein to polymersome membrane. 104 The functionality of gA is investigated through encapsulation of pyranine, a pH‐sensitive dye in polymersomes, where quenching of fluorescence intensity indicates gA activity due to transport of protons into the polymersomes. Other methods such as monitoring for fluorescence changes of the Asante NaTRIUM Green‐2 (ANG‐2) dye that is specific for Na + transport and Asante Potassium Green‐2 (APG‐2) dye that is specific for K + transport have also been used to determine gA functionality (Figure  4d ). 104 Ionomycin, which allows for transport of Ca 2+ ions, has been incorporated in PMOXA–PDMS–PMOXA‐based polymersomes or polymeric GUVs via film rehydration, and its transport functionality is studied through analyzing fluorescent increases in the calcium sensitive Asante Calcium Green (ACG) dye due to influx of Ca 2+ ions into the polymersome. 105 In addition, the permeability of ionomycin can be determined with stopped flow apparatus. 105 KcsA, which allows for transport of K + ions, has also been studied in PMOXA‐PDMS‐PMOXA polymersomes. However, the incorporation efficiency of the KcsA is only 5%, potentially due to the long drying process during electroformation, which results in aggregation and eventual degradation of the KcsA channel. KcsA insertion is confirmed with measuring the free lateral diffusion inside the polymer membrane with z‐scan FCS, where an increase in diffusion rate indicates incorrect incorporation due to protein aggregation. 59 4.1.5. Maltoporin/LamB Maltoporin or LamB is a trimeric channel in the outer cell wall of Gram‐negative bacteria that specifically transport maltose and maltodextrins and also serves as a receptor for phage λ. LamB was reconstituted into PMOXA–PDMS–PMOXA polymersomes through mixing the LamB and vesicles solution together to mimic and analyze the mechanisms of phage genome transfer into bacteria through phage binding to trigger release of DNA into the polymersome. 28 LamB functionality is determined through monitoring the change in Oxazole Yellow (YO‐PRO‐1) fluorescently labeled DNA released into the vesicle before and after phage addition. The addition of phage results in a steep increase in the fluorescence intensity, indicating that the protein is functional in inducing the injection of viral DNA. 28 This successful reconstitution of LamB in polymersomes can serve as polymeric nanocontainer that is able to translocate DNA across a synthetic membrane, which can potentially be applied in gene delivery and therapeutic applications. 4.1.6. TsX TsX is nucleoside‐specific channel‐forming outer membrane porin that allows the specific transport of nucleosides and nucleotides. TsX has been reconstituted into PMOXA‐PDMS‐PMOXA polymersomes. To determine its nucleoside specific activity, the transport of prodrug 2‐fluoroadenosine into the polymersomes via TsX was monitored via its hydrolysis to 2‐fluoroadenine 106 with a reducing sugar assay. TsX reconstituted proteopolymersomes are also used to deliver thymidine phosphorylase (TP) as an enzyme therapy strategy for mitochondrial neurogastrointestinal encephalomyopathy, where TsX functions as a channel to allow for the transport of enzyme substrate thymidine and product thymine through the polymersome. The TP enzyme activity can be determined through monitoring for thymine formation through determining the difference in absorption between thymidine substrate and thymine product at 290 nm. 133 4.1.7. MscL (hybrid vesicles) MscL is a large‐conductance mechanosensitive ion channel found in prokaryotic and eukaryotic cell membranes and play an important role in rapidly regulating turgor pressure around the cell in response to increased membrane tension. Hybrid vesicles consisting of DOPC with varying concentrations of PEO‐PBD diblock copolymer are used to reconstitute and study the folding of α‐helical MscL. 51 MscL protein is incorporated into the hybrid membrane via cell‐free expression using a construct of MscL tagged with monomeric enhanced green fluorescent protein (mEGFP) at the C‐terminus as well as a translation system. Proper folding of MscL results in an increase of GFP fluorescence intensity. The functional activity of MscL incorporation is investigated through a calcein dye release through measuring the amount of calcein release from the vesicle via fluorescence spectroscopy. 51 The ability to add pores or synthetic channels to polymersomes could lead to novel membrane composites with unique selectivity and permeability. For instance, α‐hemolysin, involved in pore formation, has been inserted into PBD‐PEO polymersomes using cell‐free co‐translational incorporation approach, which increased permeability to encapsulated calcein dye. 52 In addition to porins, synthetic pores self‐assembled from either a dendritic dipeptide or a dendritic ester have also been successfully synthesized into stable helical pores in PEO‐PBD polymersomes to enhance polymersomes permeability. 134 Similarly, synthetic porins made from carbon nanotubes have also been incorporated in PBD‐PEO copolymer‐based polymersomes. 135 Other functional modifications to polymeric membrane include incorporation of multiple channel proteins such as AlkL, OmpW, OprG and TodX, PhoE and FocA in PMOXA‐PDMS‐PMOXA polymersomes, where the combination of TodX and PhoE led to the most significant improvement in mass transfer compared to polymersomes without MPs. 136 This study primary focuses on improving mass transfer of polymersomes and not biophysical characterization of the reconstituted MPs. Other applications of channel proteins reconstituted polymersomes include being nanoreactors, where the channel proteins allow for selective permeation of water, nucleotides, and molecules into polymersomes to facilitate enzymatic reactions. 96 , 105 , 136 4.2. Protein complexes for active transport 4.2.1. NADH:ubiquinone oxidoreductase (Complex I) Amphiphilic block copolymer PMOXA–PDMS–PMOXA was used to study the electron‐transfer activity of bacterial respiratory enzyme complex NADH:ubiquinone oxidoreductase (Complex I). 90 Complex I couples the transfer of electrons from NADH to ubiquinone performed by a series of redox centers with a translocation of protons across the membrane. EPR, a well‐known technique to detect free radicals, was used to detect the presence of radical anions of the electron acceptors, which accounts for the in situ activity of Complex I in proteopolymersomes (Figure  5a ). 90 , 137 NADH/ferricyanide oxidoreductase activity assay proved that a high fraction of Complex I was inserted with desired orientation, favoring electron transfer from the vesicles into their membranes (Figure  5b ). 90 Furthermore, ubiquinone 2 (CoQ2), known to be involved in the natural mechanism of energy conversion as an electron acceptor, was used to indicate the amount of electron transfer from the vesicles into their membranes. The addition of NADH to the proteopolymersome solution generated an EPR spectrum of CoQ2 with a significantly higher intensity, indicating the incorporation of more reduced forms of CoQ2 in the proteopolymersomes, which proves that Complex I mediate the electron transfers when reconstituted in the polymer membrane. 90 FIGURE 5 Structural and functional studies of membrane protein complexes with active transport in polymersomes. (a) Electron paramagnetic resonance (EPR) spectrum of NADH:ubiquinone oxidoreductase (Complex I) reconstituted in polymersomes. The EPR spectrum of Complex I in polymersome is similar to that of native Complex I solubilized in surfactants, indicating that chain of electron transfer was not affected by the reconstitution process. The five arrows with + and * indicate the signature of EPR spectrum specific to native Complex I. 137 (b) Measurement of NADH/ferricyanide oxidoreductase activity to determine the preferential orientation of Complex I in polymersomes. The activity of native Complex I solubilized in surfactants (Curve A) is preserved after incorporation in the polymer membrane (Curve B), and Curve C indicates no activity from empty polymersomes. The reduction of activity in proteopolymersomes is due to reduced fraction of incorporated protein, as well as partially unoriented Complex I. Source : Figure  4a,b is reproduced with permission from reference 90 , Copyright 2010, John Wiley and Sons. (c) Schematic representation of an ATP‐producing polymersome based on bacteriorhodopsin (BR)‐ATP synthase coupling system. (d) Intravesicular pH change with respect to light illumination as a measure of proton pumping activity of BR reconstituted polymersomes. (e) Photosynthetic ATP production in the BR‐ATP synthase reconstituted polymersomes under illuminated condition, which is coupled with proton pumping activity of BR. Source : Figure  4c–e is reproduced with permission from reference 61 , Copyright 2005, American Chemical Society, as well as from reference 138 , Copyright 2013, MDPI 4.2.2. ATP synthase and bacteriorhodopsin (BR) ATP synthase is composed of two domains, the membrane integrated F 0 and the soluble F 1 . Coupling activity between the F 0 and F 1 complexes drives proton movement toward the F 1 side of the membrane, resulting in ATP synthesis (Figure  5c ). 61 , 138 The rotating activity of F o F 1 ‐ATPase in the amphiphilic triblock copolymer PEtOz−PDMS−PEtOz can be maintained to synthesize ATP, using the photoinduced proton gradient generated from BR activity. 61 , 62 , 107 This is the first successful biosynthesis through coupled reactions between reconstituted transmembrane proteins in a single proteopolymersome, and the first to demonstrate motor functionality in a polymer membrane. The production of photoinduced electrochemical proton gradients from both BR and BR‐ATP synthase reconstituted proteopolymersomes can be measured by the addition of pyranine inside the proteopolymersomes. The relative fluorescence intensity ratio at 456 nm and 402 nm indicates the H + ion concentration, and hence the internal pH in proteopolymersomes can be quantified (Figure  5d ). 61 , 138 A bioluminescence assay using luciferin and luciferase is used to quantify ATP production, since luciferase catalyzes the oxidation of luciferin by consuming ATP and shows that ATP production increases significantly with increasing light incubation, indicating functional reconstitution of ATP synthase (Figure  5e ). 61 , 62 , 107 , 138 However, proteopolymersome‐based studies of F o F 1 ‐ATPase are limited by difficulties involved in the reconstitution process, such as low membrane permeability due to its synthetic nature and material inhomogeneity, thereby preventing continuous substrate and products transport across the channel protein and reduction in enzymatic reactions. Furthermore, some reconstitution conditions can be harsh to the F o F 1 ‐ATPase, which is made up of multiple subunits that can be easily disrupted. Therefore, there is a need for better optimized membranes such as hybrid vesicles formed by the blends of lipids and block copolymers that can result in better reconstitution of such MP complexes. 139 4.2.3. Proton pump—proteorhodopsin Purified light‐activated photo pump proteorhodopsin (PR) can be reconstituted in polymersomes formed from PEG‐PDPA‐PSS. 70 PR has a distinct polarity where the intracellular side has a slight positive charge, which is further increased through engineering a decahistidine‐tag at this side. On the other hand, the extracellular side bears a slightly negative charge. As a result, incorporation of PR into the polymersome allowed for its directed insertion where the PR would orientate with the negatively charged PSS group. This functionality of PR is confirmed by a light‐dependent pH change of the proteopolymersome solution, indicating the intended orientation. 70 In another study, PR is reconstituted in polystyrene‐ b ‐poly(4‐vinyl‐ N ‐methylpyridine iodide) 2 (PS‐P4MVP 2 ) polymersomes via spontaneous reconstitution at pH 7.4. 108 The membrane bilayer thickness is around 3.4–4.4 nm depending on increasing PS chain length, while the length of PR is less than 3.5 nm, indicating that hydrophobic mismatch may occur during reconstitution. 108 However, the results show successful PR reconstitution, suggesting that the polymer membrane is conformationally active to match the hydrophobic domain of PR. The reconstitution and packing of PR in these proteopolymersomes are investigated with SAXS, revealing a two‐dimensional hexagonally packed PR lattice in individual proteopolymersome membrane bilayers, consistent with previously conducted orientation studies. The secondary structure and structural stability of PR was further confirmed using Raman and solid‐state NMR (ssNMR) spectroscopy through labeling with 13 C and 15 N radioisotopes. 108 Time‐resolved visible spectroscopy through flash‐photolysis was used to determine PR functionality through monitoring whether it maintained key photocycle steps and turnover kinetics, where they showed that the PR reconstituted in proteopolymersomes retained the presence of M intermediate at 420 nm, absence of strong signals from the 13‐cis‐dark state at 600 nm, and relatively fast photocycle turnover kinetics. 108 4.2.4. Proton pump—cytochrome bo3 (hybrid vesicles) The MP cytochrome bo3 (Cyt‐bo3), a redox‐reaction driven proton pump that couples oxygen reduction to proton transport, has been studied in hybrid lipid vesicles made from diblock copolymer PBD‐PEO and 1‐palmitoyl‐2‐oleoyl‐sn‐glycero‐3‐phosphocholine (POPC) phospholipid, with varying percentages. 89 Hybrid vesicles are used because they can combine both the higher stability of polymer components and the more annular and biocompatible lipid bilayer. The hybrid vesicle is formed via optimization of the reconstitution techniques, where extrusion of the hybrid vesicles, followed by gradual destabilization of the vesicles by small amounts of detergents, and eventual incorporation of the MP yielded spherical vesicles with size between 75 and 116 nm, confirmed with DLS and TEM. 89 To determine the optimal ratio between POPC and PBd 22 ‐PEO 14 that enables the highest Cyt‐bo3 activity in the hybrid vesicles, the initial rates of decylubiquinone oxidation are measured via absorbance reading at 275 nm, where an equimolar ratio between POPC and PBD‐PEO yields the best hybrid vesicle with Cyt‐bo3 having high initial activity and slow loss in activity. 89 Comparatively, Cyt‐bo3 is not functionally reconstituted in PBD‐PEO only based polymersomes, due to the poor biocompatibility of its membrane, indicating the need for hybrid vesicles that combines POPC liposomes biocompatibility to high stability of the PBD‐PEO polymersomes. 89 In a similar study with Cyt‐bo3 reconstitution in hybrid vesicles, the authors further investigated the hybrid membrane characteristics and showed that these membranes have less permeability than lipid bilayers, and 50 mol% PBD‐PEO hybrid vesicles have high initial reconstituted activity and retain around 20% of initial activity after 500 days. 140 Cyt‐bo3 has also been reconstituted in PDMS‐ g ‐PEO with and without phosphatidylcholine (PC) and showed that it had the highest activity in hybrid vesicles, as measured by the level of oxygen reduction, while the activity in either polymersomes or liposomes was about the same. 141 4.2.5. NaAtm1 and human P‐glycoprotein (hybrid vesicles) ATP binding cassette (ABC) proteins including Novosphingobium aromaticivorans Atm1 protein, which mediates the active efflux of toxic metals complexed to glutathione, and human P‐glycoprotein (Pgp), which transports hydrophobic drugs, have been reconstituted and studied separately in hybrid vesicles consisting of both phospholipids and PBD‐PEO. 30 Reconstitution of either human Pgp or Atm1 protein is confirmed by density gradient centrifugation, as well as low passive permeability to a fluorescent probe (calcein acetomethoxyl‐ester) (C‐AM). Functional reconstitution of Atm1 or Pgp proteins is determined by ATPase functional assay which measures the liberation of inorganic phosphate. 30 Besides the examples on Cyt‐bo3 proton‐pumping oxygen reductase and ABC transporters, transmembrane protein complexes have a primary application of ATP production, which is coupled to active transport of protons under light stimulation. 142 Research has focused on optimizing artificial photosynthetic systems for ATP production to advance toward engineering of artificial cells. A limitation of the current approach lies in ATP being produced outside proteopolymersomes or proteoliposomes, which does not allow for more quantitative mechanistic studies such as mimicking in‐cell biochemical reactions. An improvement to this has been reported in a study using liposome GUVs to produce ATP where multilayer vesicles were formed like the structure of plant cells and ATP was harvested in the inner membranes to drive actin polymerization and carbon fixation continuously. 143 More MPs capable of energy harvesting could be reconstituted in polymersomes 94 to study their energy production capability as well as expand the research on artificial cells that can perform generation and consumption of energy all within themselves. 144 , 145 5. MEMBRANE RECEPTORS Membrane receptors are specialized protein molecules attached to or integrated into the cell membrane. Membrane receptors play important roles such as facilitating communication between the cell and the extracellular environment through interaction with specific ligands including hormones and neurotransmitters. 146 Membrane receptors have been studied in liposomes; however, the incorporated proteins are unstable and hinder the measurements of receptor functions. 147 Hence, receptor‐based proteopolymersome systems have been engineered with reconstitution of receptors that are responsible for signal transduction (G‐protein‐coupled receptors, GPCRs), cell–cell communication (Cldn2), immune response (major histocompatibility complex I, MHC‐I) and cell adhesion (peptide anchors) (Table  1 ). 5.1. GPCRs (DRD2, CXCR4, and GLP‐1R) GPCRs represent the largest class of MPs in the human genome and play a key role in mediating most of our physiological responses to neurotransmitters, hormones, and external stimuli. Hence, they are potential therapeutic targets for a broad spectrum of diseases and the study of their structure–function relationship is important. 148 Several proteopolymersome systems with GPCRs incorporation have been generated through cell‐free synthesis, including the reconstitution of dopamine receptor D2 (DRD2), 53 chemokine C‐X‐C receptor 4 (CXCR4) 109 and glucagon‐like peptide‐1 receptor (GLP‐1R) into polymersomes formed by PMOXA‐PDMS‐PMOXA or PBD‐PEO block copolymers. 110 In these proteopolymersomes, successful GPCR insertion is characterized by flow cytometry, SEC, and Western blots. The physiologically correct folding and orientation of reconstituted GPCR is confirmed by binding of respective conformational specific antibodies and native or synthetic ligands (Figure  6a ), 53 as characterized by surface plasmon resonance (SPR), flow cytometry, I‐125 radioactive ligand binding or fluorescence‐based assays, with non‐GPCR proteopolymersomes or polymersomes without MP incorporation used as controls which showed no binding. 53 , 109 , 110 FIGURE 6 Characterization of membrane receptor‐based proteopolymersomes and their applications. (a) The structure–function relationship of membrane receptors is characterized by binding of conformational antibodies and native ligands to illustrate the proper folding and functions of the receptors, respectively. Schematic was created with BioRender.com. Source : Reproduced with permission from reference 53 , Copyright 2012, John Wiley and Sons.(b) Western blot of in vitro expressed claudin‐2 (Cldn2) in the absence or presence of polymersomes or liposomes. (c) SPR measurements showing the binding of Cldn2 reconstituted proteopolymersomes to anti‐Cldn2 functionalized surface but not normal mouse IgG surface. There is also no significant binding between empty polymersomes without Cldn‐2 expression and the anti‐Cldn2 surface. Source : Figure  5b,c is reproduced with permission from reference 52 , Copyright 2011, Springer Nature.(d) Engineering of an artificial antigen‐presenting cell by cell‐free in vitro synthesis and incorporation of MHC‐I into polymersomes (red vesicles) and the attachment of MHC‐I proteopolymersomes onto the 3D surface of microbead as a support (purple), forming MHC‐I proteopolymersome‐beads. 111 (e) Size‐exclusion chromatography (SEC) characterization of eGFP (top) and eGFP‐fused transmembrane domain of the rabbit cytochrome b5 (Cyt‐b5) (bottom) proteopolymersomes. Black dashes represent quantification of polymersomes by measuring light absorbance at 350 nm. Green and red solid lines show the presence of eGFP characterized by fluorescence signal (green, made fresh; red, after 6 weeks of storage). (f) There is an inversely proportional dependency of the immobilized eGFP‐Cyt‐b5 molecules per polymersome with increasing polymersome concentration. The polymersome surface area becomes limiting below 0.05% w/v. Source : Figure  5e,f is reproduced with permission from reference 113 , Copyright 2016, Springer Nature. Schematics were created with BioRender.com. In the individual system, the binding of dansyl‐labeled dopamine to DRD2 proteopolymersome illustrates a half‐maximal effective concentration (EC 50 ) of 30 μM, which is much higher than the known EC 50 of its native ligand dopamine in the nanomolar range. 149 While it is not discussed, this discrepancy can be due to the low amount of protein incorporation at only 25%, the presence of dansyl label leading to steric hindrance, and potential protein misfolding due to cell‐free synthesis that resulted in reduced ligand binding capacity. In the CXCR4 system, comparable dissociation constants of native ligand SDF‐1α in CXCR4 proteopolymersome (8.4 nM) and native membrane (1.4 nM) are identified. It was suggested that the lower affinity of the ligand for proteopolymersome could be due to the absence of G proteins in the synthetic system, which may affect CXCR4 conformation and alter ligand binding affinity. 150 In the GLP‐1R study, the binding affinity (K d ) of N‐terminal extracellular domain specific antibody is 18.6 nM, which indicates that some GLP‐1R assumed a correct orientation due to the accessibility to the N‐terminal domain. However, there is also some binding of the 1D4 antibody to the C‐terminal C9 tag, suggesting the presence of reversely incorporated GLP‐1R in the proteopolymersomes. 110 In addition, the low SPR response units during antibody binding show the presence of a low percentage of GLP‐1R incorporation into polymersomes. To promote folding of GLP‐1R for enhanced functionality, Fos‐choline 14 (Fos14) detergent is introduced, which functions as a chemical chaperone. Fos14 assists the folding of GLP‐1R and mediates a more stable incorporation of GLP‐1R into the polymersomes. 110 Radioligand competition binding assay between 125 I‐labeled GLP‐1 as tracer and native peptide ligand exendin‐4 confirms the functionality of these Fos14‐assisted GLP‐1R proteopolymersomes. The K d of GLP‐1R proteopolymersomes (54.3 nM) determined is similar to that of GLP‐1R in native membrane (37.8 nM). 110 5.2. Claudin‐2 Claudin‐2 (Cldn2) is a transmembrane receptor that promotes cell–cell adhesion by forming homodimer with another molecule in neighboring cell. 151 Cldn2 is a component of the tight junction and forms cation‐selective and water permeable paracellular channel. 151 It also acts as a signal modulator and integrator that affects cell proliferation and migration, which may be relevant in both cancer biology and tissue regeneration. 151 Cldn2 is inserted into PBD‐PEO polymersomes using a cell‐free in vitro synthesis method and characterized for reconstitution using SEM and Western blots (Figure  6b ). 52 Staphylococcal α‐hemolysin, which is a pore‐forming MP, is used as a positive control through dye leakage assay to demonstrate spontaneous MP insertion into PBD‐PEO polymersome. Cldn2 proteopolymersome is also characterized by monitoring the binding of specific antibodies against Cldn2 using SPR. SPR measurements indicate that there is binding between Cldn2 proteopolymersomes and the immobilized anti‐Cldn2 IgG (ΔRU of 128 ± 14) but not with normal mouse IgG (ΔRU of 4 ± 1) functionalized surface (Figure  6c ). 52 There is no significant binding between polymersomes without Cldn‐2 expression and the anti‐Cldn2 IgG functionalized surface (ΔRU of 17 ± 9). Cldn2 has also been reconstituted into liposomes for direct comparison between the functionality of incorporated protein in both types of nano‐vesicles. The increased binding to anti‐Cldn2 by Cldn2 proteopolymersomes as compared to Cldn2 proteoliposomes not only indicates the correct folding and orientation of reconstituted Cldn2 but also the enhanced stability of protein insertion into polymersomes than liposomes for MP studies. 52 5.3. MHC‐I To induce immune‐modulatory response, it is essential for MHC‐I proteins to be expressed on the extracellular‐side of antigen‐presenting cells (APCs) for molecular recognition of pathogens by T cells. Artificial APCs, which can behave as polymer‐based synthetic immunological synapses, are often used to enhance MHC‐I antigen presentation. 152 A new type of artificial APC is developed using cell free in vitro synthesis method of incorporation of MHC‐I molecule H‐2Kb preloaded with chicken ovalbumin (OVA) into the bilayer membranes of ABA‐RBOE‐PS‐SA nano‐vesicle beads that are made from self‐assembly of block copolymers (Figure  6d ). 111 After confirming the structure and function of the incorporated MHC‐I, the MHC‐I H‐2Kb‐OVA proteopolymersomes serve as artificial APCs to promote antigen recognition and immunological synapse formation in CD8 + T cells isolated from OT‐I transgenic mice and induced T‐cell activation. 111 The engineered MHC‐I proteopolymersome represents a promising platform for studying and quantifying the spatio‐functional interactions between artificial APC and T‐cell and hence can have further applications such as HTS of T‐cell regulating compounds. In another study, pH‐responsive nanoparticles composed of triblock copolymers ([BMA‐ co ‐DEAEMA]‐b‐[DMA‐ co ‐PDSMA] polymers) doped with pyridyl disulfide functionalized monomer (PDSMA) for antigen conjugation are incorporated with MHC‐I, for use as artificial APCs. 153 Although different from MHC‐I proteopolymersomes, the MHC‐I conjugated nanoparticles are able to enhance MHC‐I antigen uptake in dendritic cells, consistent with that observed in MHC‐I proteopolymersomes. 153 5.4. Peptide anchors (CecA, Cyt‐b5, Vam3p, lysis protein L) Amphiphilic peptides have been used as anchors to decorate polymersome for additional surface functionality including anti‐microbial activity as well as for membrane surface anchoring of water soluble proteins. 154 , 155 An example is the reconstitution of a fusion protein (CecA‐eGFP) based on the antibacterial peptide Cecropin A (CecA) and the enhanced green fluorescent protein (eGFP) into polymersomes formed by triblock copolymer polyisobutylene‐polyethylene glycol‐polyisobutylene (PIB–PEG–PIB). 112 Successful reconstitution of CecA into polymersomes is characterized by the folding of a random coil into α‐helix in presence of polymersomes detected by CD and the co‐localization of CecA and polymersomes as shown through SEC and tryptophan fluorescence measurements. 112 A follow‐up study has shown a similar reconstitution of natural peptide anchors including eGFP fused transmembrane domains of cytochrome b5 (Cyt‐b5), viral lysis protein L of the bacteriophage MS2, and yeast syntaxin VAM3 (Vam3p) with CecA‐eGFP as a positive control. 113 The presence of natural peptide anchors allows the tethering of water‐soluble protein or enzyme to membranes. These natural peptides are reconstituted into PMOXA–PDMS–PMOXA polymersomes. The display of eGFP on the surface of polymersomes illustrates the proper insertion of the peptide anchors into the polymeric membranes and co‐localization of these peptides and polymersomes is shown through SEC (Figure  6e ). 113 The study also shows an inversely proportional dependency of the immobilized eGFP‐Cyt‐b5 molecules per polymersome with increasing polymersome concentration where the polymersome surface area becomes limiting below 0.05% w/v (Figure  6f ). 113 Importantly, these peptide anchors do not form pores or disintegrate the membranes, illustrating their potential to anchor water soluble proteins on membrane surface. 113 , 154 While the above membrane receptor studies are conducted in proteopolymersomes, there are other receptor‐based studies performed in proteoliposomes as well as in lipid and polymer bilayers. 156 , 157 , 158 , 159 , 160 , 161 , 162 , 163 Some of these important MP complexes, such as β‐site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) and γ‐secretase, 156 , 157 , 158 , 159 , 160 may be further studied in polymersome for structural and functional comparison in different nano‐vesicles. The techniques used in these liposome‐related MP studies, including FCS, fluorescence recovery after photobleaching (FRAP), single molecule tracking (SMT), total internal reflection fluorescence spectroscopy (TIRFS), fluorescence resonance energy transfer (FRET) and continuous‐wave EPR (CW‐EPR), could also be applied to the characterization of receptor–ligand interactions and changes in MP conformations and oligomeric states in proteopolymersomes. 161 , 162 , 163 6. FACTORS AFFECTING MP STUDIES IN PROTEOPOLYMERSOMES A good cell membrane mimetic should be morphologically similar to the biological bilayer membrane, equivalent thickness in a liquid crystalline phase, without any change in the membrane fluidity, which may affect the equilibrium distribution of the different MPs. 164 There are several factors that affect the folding, function, and dynamic equilibrium of MPs in proteopolymersomes. We will discuss three key groups of factors below, including membrane composition, MP expression and reconstitution system, and protein states (Table  2 ). TABLE 2 Factors affecting membrane protein (MP) reconstitution and quality of structural and functional characterization Optimization parameters Factors affecting MP reconstitution Effects on MP structural and functional characterization MPs References Membrane composition Polymer composition/asymmetricity Determine the physiologic orientation and function of the inserted MP; molecular weights for different polymer blocks can facilitate efficient protein encapsulation and stabilization AQP0 PR 29 , 70 , 165 Polymer flexibility/curvature Determine the physiologic orientation and function of the inserted MP AQP0 OmpF 29 , 166 , 167 Polymer membrane thickness Increased thickness increases MP conformational stability Complex I 28 , 90 , 166 , 168 Membrane protein expression and reconstitution system Cell‐based protein purification and reconstitution Advantages: Addition of detergents allows for ease of MP solubilization and can facilitate MP folding Disadvantages: Cytotoxicity, misfolding, and aggregation OmpF Cldn‐2 169 , 170 , 171 Cell‐free co‐translational incorporation Advantages: No cytotoxicity, pure and homogenous protein formation, can be solubilized with milder detergents, less chance of protein misfolding Disadvantages: Lower final protein yields OmpF Cldn‐2 169 , 170 , 171 Hydrophobic mismatch Decrease the equilibrium concentration or activity of MP OmpF 29 , 64 , 167 , 172 , 173 Detergent concentration High concentrations may decrease MP activity NaAtm1 Pgp FhuA OmpF 30 , 101 , 132 Rate of detergent removal Slow rate of removal results in smaller polymersomes; fast rate of removal results in larger polymersomes AQP0 102 Size of vesicles Smaller vesicles are more compatible with biological membranes and increases MP stability; large vesicle interior volume lowers MP membrane concentration, and increases NMR structural study difficulty Cldn‐2 52 , 174 , 175 Preformed vesicles Limit the number of MP that can be incorporated due to high energetic expenditure AQP0 102 Polymer/lipid‐to‐protein ratio A low polymer/lipid to MP ratio increases the quantity of MPs available in polymersomes for study; a ratio of 1:1 has been shown to have high NMR sensitivity MsCL Influenza M2 proton channel 176 , 177 Protein amount/concentration High protein concentration increases MP reconstitution; saturated protein concentration decreases MP reconstitution OmpF TsX 25 , 26 , 27 , 28 , 60 , 96 , 97 , 102 , 106 Protein states Monomers/purple membrane Determine the physiologic orientation and function of the inserted MP BR/F 0 F 1 ‐ATP synthase 107 Environmental condition Light illumination increases MP activity PR 60 , 61 , 62 , 107 Immobilization of polymersomes on surfaces/free flowing polymersomes MP activity decreases when polymersomes are immobilized OmpF 96 Correlation time of the MP–surfactant complex (PSC)/Tumbling rate Determine the ability of protein structure to be resolved by NMR. Fast‐tumbling small PSCs (<100 kDa) can be studied by solution NMR; slow reorienting aggregates are more suitable to be characterized by solid‐state NMR DAGK 178 , 179 6.1. Membrane composition The asymmetricity of copolymers used in polymersome synthesis could result in different thickness and fluidity of the formed polymersomes, thereby affecting the orientation and functionality of the inserted MPs. A study with aquaporins with His‐tag shows that the percentages of nonphysiological orientation as characterized by the exposure of His‐tag to the external solution for lipids and ABA triblock copolymer were near 50%, which is in reasonable agreement with random insertion into the membranes. However, for ABC and CBA triblock polymers, there was a preferred physiologic orientation of 72% in the ABC system, and a nonphysiologic orientation of 81% in the CBA system (Figure  7a ). 29 In addition, designing triblock copolymers with different molecular weights for the A and C blocks can facilitate efficient protein encapsulation and stabilization. This can be done through having the longer end with a higher molecular weight segregating on the outside of the polymersome due to a larger radius of curvature with a differing volume fraction, and the smaller end segregating on the inside of the polymersome. 165 The conformational freedom and flexibility of the polymers are key factors to promote MP incorporation without involving a loss of free energy. Hydrophobic mismatch between the polymer and MP affects protein structure and functionality (Figure  7b ). 166 For instance, in an OmpF reconstituted proteopolymersome, a thin 3 nm polymer bilayer matches with the protein length and results in functional protein without deformation of the polymer membrane. In contrast, a 6 nm polymer bilayer shows a strong negative mismatch, resulting in symmetric deformations in the upper and the lower leaflets, and could potentially lead to an expulsion of the MP. 167 A membrane formed from amphiphilic block copolymers can withstand larger hydrophobic mismatches of more than 22% in the membrane thickness than lipid‐based membranes, which can typically only withstand mismatches of 2%–3%. 167 Thus, increased flexibility of polymeric membranes can lead to a more successful biomolecule insertion. On the other hand, PR has been functionally reconstituted into highly stiff and stable glassy block copolymer membranes with the polystyrene hydrophobic block, 167 indicating that the conformation and flexibility also depends on the type of MPs inserted. FIGURE 7 Factors affecting reconstitution efficiency and quality of membrane protein study. (a) Polymer asymmetricity affects orientation of aquaporin 0 insertion into polymersomes. Source : Reproduced with permission from reference 29 , Copyright 2004, John Wiley and Sons . (b) Hydrophobic mismatch between the polymer and membrane protein near an inclusion in a polymeric bilayer. The chains in the unperturbed bilayer are highly stretched in order for much shorter proteins to match the thickness without undergoing significant compression when compared to the free chain radius of gyration. 2L m is the thickness of a flat bilayer and 2L p is the inclusion thickness. Source : Reproduced with permission from reference 166 , Copyright 2003, Elsevier . (c) Higher detergent concentrations are required by vesicles made up by a higher proportion of block copolymers (PBd‐PEO) to reach saturation (C sat ) and solubilization (C sol ) points, indicating that there is an increase in stability with inclusion of block copolymers in vesicles. Source : Reproduced with permission from reference 30 , Copyright 2020, MDPI. (d) Effect of increasing lipid/polymer to NADH:ubiquinone oxidoreductase (Complex I) concentration on decyl‐ubiquinone oxidoreductase activity. Increasing lipid/polymer to membrane protein ratio results in more functional activity. Source : Reproduced with permission from reference 90 , Copyright 2010, John Wiley and Sons. (e) Preparation method controls proton vectoriality in bacteriorhodopsin (BP) proteopolymersomes. Incorporation with BR monomer in the absence of ethanol results in the light‐induced change in pH exhibiting negative values with increase in illumination time. Solid circles indicate illuminated condition, while hollow circles indicate dark‐incubated. (f) Protein states affect the functional activity of the reconstituted membrane proteins in polymersomes. BR‐ATP synthase exhibits an acceleration of ATP synthesis when polymersomes are prepared without ethanol (red). Preparation of polymersomes with ethanol (blue) shows an initial increase in ATP synthesis which decreases with time. Source : Figure  7e,f is reproduced with permission from reference 107 , Copyright 2006, IOP Publishing Nano‐vesicles, in particular the SUVs, are more stable, have a smaller curvature than GUVs, and provide a local environment that is more similar to that of biological membranes for MPs. This property makes them more suitable for MP studies, particular for structural studies. 20 , 43 , 180 In addition, a key advantage of these nano‐vesicles lies in the clearly defined compartments segregated by the copolymer layers, which creates a concentration gradient that allows the transport of solutes and hence the measurement of the activity of pore‐forming proteins across the membrane. 104 , 123 , 181 Hence, controlling the size of the polymersomes is important in determining their applications and methods used to study MPs in proteopolymersomes. 182 Polymersomes, although stable and come with many benefits, are not always favorable environments for MP reconstitution, and in some cases, modifications to the membrane environment are required to achieve the desired functions. 30 , 183 These issues motivate the modification of polymersome properties to enhance their bio‐functionality, such as blending block copolymers and phospholipids to create hybrid vesicles, with the goal of combining the best features of these two materials such as having the chemical versatility and robustness of polymersomes with the biocompatibility and biofunctionality of liposomes (Figure  7c ). 30 , 183 , 184 6.2. MP expression and reconstitution system Cell‐free protein expression systems have been widely adopted to produce structurally intact mammalian MPs, 185 and to overcome the limitations of the conventional protein production with use of E. coli or yeast. 116 , 176 Cell‐free protein production generates a large amount of properly folded and biologically active proteins to be mixed with sufficient copolymers for optimal reconstitution for extensive MP studies. While cell‐free approaches come with many advantages, the required enzymes supplemented in vitro which may be inferior to the quality control systems found in cells, and may contribute to making some misfolded and inactive MPs in the mixture that confounds quantifications of MP properties. 186 Therefore, it is important to optimize the protein expression and reconstitution system to use for MP studies depending on the quantity and stability of the MPs required. Choice of detergents and organic solvents in reconstitution may affect the stability of MPs, and hence the efficiency of reconstitution for MP studies. The use of detergents is important in the extraction of large quantities of MPs which is required for techniques such as NMR to achieve a significant detection signal. However, high concentration of detergents used can also lead to formation of detergent micelles which can destabilize MPs. Consequently, careful control of detergent concentration needs to be done to increase MPs stability. 166 , 176 , 187 Organic solvents are necessary for polymersomes solubilization and are used to mix with the MPs solution to facilitate protein reconstitution. However, the presence of organic solvents can denature MPs, hence decreasing their functional activity. Therefore, new methods such as polymer rehydration and droplet microfluidics, which eliminates the need for organic solvents, have been discovered for reconstitution to improve MPs quality and activity in multiple studies. 27 , 43 , 61 , 62 , 90 , 107 The lipid/polymer‐to‐protein concentration and ratio also affects MP activity. 188 For instance, a ratio of 1:1 results in the highest NADH‐decylubiquinone oxireductase activity (Figure  7d ). 90 6.3. Protein states The protein states of MPs used also affect its orientation of insertion in the polymersomes. This can be seen through the comparison between insertion of BR in monomeric state and BR in the form of purple membrane (PM). 61 , 62 , 107 Using the BR monomer, results showed that light‐induced pH exhibited negative values with increasing illumination time (Figure  7e ). This indicates that protons were being pumped inwards into the core of the polymersomes, which is opposite to the outward pumping with BR in purple membrane. This also shows that BR molecules are preferentially positioned with the C‐terminus facing outward and inward in the proteopolymersomes when reconstituted with BR monomer and BR in purple membrane respectively. 61 , 62 , 107 Changes in protein states also affect the functional activity of MPs. In the case of proteopolymersomes of BR in PM state, BR‐ATP synthase exhibited an acceleration of ATP synthesis (Figure  7f ). 107 When the reconstituted BR is in the monomeric state, BR‐ATP synthase activity had an initial slow activity and increased progressively over the course of 30 min when the rate decreased. 107 In a reconstituted proteopolymersome, changes in protein concentration used or amphiphile‐to‐MP ratio can affect proteopolymersomes morphologies, quality of protein crystals needed for MP structural study, 102 , 176 as well as MP orientation and activities, 52 , 61 , 62 , 107 and quantities available in proteopolymersomes for study. The use of excellent quality of protein crystals has also been shown to allow the elucidation of small molecule interactions with influenza M2 proton channels in lipid bilayers as well as the determination of the high‐resolution structures of their complexes. 177 The correlation time of the protein‐surfactant complex (PSC) also affects the ability of MPs to be resolved by NMR, where the fast‐tumbling small PSCs below 100 kDa (e.g., diacylglycerol kinase [DAGK] in detergent micelles) can be studied by solution NMR, 178 while slow reorienting aggregates are more open to ssNMR. 179 Finally, there is a difference in the functionality of MPs inserted into free vesicles as compared to immobilized vesicles. It is observed that MPs in immobilized vesicles have 6.5 times lower activity than the free vesicles in solution. 189 Two possible reasons can explain this phenomenon. First, it can be due to the presence of an unstirred aqueous layer at the polymer‐membrane solution interface leading to the formation of a diffusional barrier for otherwise rapidly permeating substrate. 189 Second, the positioning of the nanoreactors toward the surface and the immobilization on the solid support may result in a reduced accessibility of the MPs. 96 7. CELL MEMBRANE MIMETICS AS PLATFORMS FOR HTS IN DRUG DISCOVERY New in vitro tools and models that can directly monitor the structural and functional properties of MPs are increasingly needed to enable the identification of novel lead compounds that can guide preclinical drug developments. Currently, majority of the HTS campaigns in drug discovery make use of cell‐based biosensors and related secondary assays to identify small molecule modulators that target MPs. Although cell‐based platforms have multiple advantages including being more physiologically relevant, nonspecific targeting of drug compounds remains as a major limitation as drug compounds can interact with multiple proteins or targets in the cells. They also have the disadvantage of random insertion of gene of interest into the cell genome that can disrupt the expression of some endogenous proteins. 190 , 191 , 192 , 193 Hence, the characterization of the interactions between drug candidates and MPs using a cell‐free system to directly observe their functional modulation and structural perturbation in a high‐throughput setting can greatly facilitate the speed, specificity, and quality of drug discovery. 192 MP inserted nano‐vesicles such as proteopolymersomes and proteoliposomes, either freely residing in microplates or immobilized onto a membrane bilayer, serve as excellent cell‐free HTS platforms (Figure  8a ). 196 , 197 FIGURE 8 Proteopolymersomes and proteoliposomes as high‐throughput screening (HTS) platforms for drug discovery. (a) Immobilized proteopolymeromes or proteoliposomes, either through free‐flowing proteo‐nanovesicles residing in multiwell plates (left) or tethering of proteo‐nanovesicles to a bilayer support (right), can be used for HTS drug discovery. Binding of small molecules can alter membrane protein conformation and/or function. (b) Saturation binding of iodine‐125 ( 125 I) radiolabeled SDF1α ligand to CXCR4 receptor incorporated proteopolymersomes as a proof‐of‐concept study that the proteopolymersomes can be utilized to screen for small molecule binders that modulate membrane receptor structures and functions. Source : Reproduced with permission from reference 109 , Copyright 2014, PLOS. (c) HTS drug discovery of 3520 compounds using Hepatitis C Virus p7 Viroporin proteoliposomes and a fluorescence dye permeability assay. A 1.8% hit rate is observed. Source : Reproduced with permission from reference 194 , Copyright 2011, SAGE. (d) A HTS platform in 1536‐well plates developed using hERG channel proteoliposomes and a fluorescence dye permeability assay. A positive control compound, dofetilide, is illustrated with an increase in dye permeability, indicating the ability of the HTS platform to be used to screen for compounds that modulate the hERG channel. Source : Reproduced with permission from reference 195 , Copyright 2016, National Academy of Sciences, USA. Schematics were created with BioRender.com. 7.1. Structural and conformational screening HTS of small molecules can be performed based on either modulating the protein–protein interactions (PPIs) 198 , 199 or perturbation of protein conformational dynamics, which directly corresponds to protein functions. 200 , 201 For example, multip

📖 中文全文 Chinese Full Text

中文

3332 btm 生物工程与转化医学 Bioeng Transl Med Wiley PMC9842050 9842050 9842050 36684106 10.1002/btm2.10350 聚合物囊泡在膜蛋白研究与药物发现中的应用:进展、策略与展望 Lo Chih Hung 1 2 ✉ Zeng Jialiu 1 3 4 ✉ 1 新加坡南洋理工大学李光前医学院,新加坡 2 美国马萨诸塞州波士顿哈佛医学院布莱根妇女医院神经内科 3 美国马萨诸塞州波士顿大学生物医学工程系 4 美国马萨诸塞州波士顿大学化学系 *

通讯作者 Chih Hung Lo 与 Jialiu Zeng,新加坡南洋理工大学李光前医学院,新加坡 308232 邮箱:chihhung.lo@ntu.edu.sg 与 jialiu.zeng@ntu.edu.sg

✉ 通讯作者。2022年6月28日;2022年8月1日;e10350;e10350;2023年1月19日 © 2022 作者。《生物工程与转化医学》由Wiley Periodicals LLC代表美国化学工程师学会出版。这是一篇根据 http://creativecommons.org/licenses/by/4.0/ 许可协议发布的开放获取文章,只要正确引用原始作品,允许在任何媒介中使用、分发和复制。

摘要 膜蛋白(MPs)在细胞信号通路中发挥关键作用,并负责细胞间及细胞内的相互作用。功能异常的膜蛋白与多种疾病的发病机制直接相关,已成为制药行业中最受关注的靶点之一。然而,由于膜蛋白具有两亲性,需要生物膜或膜模拟物提供保护,因此其研究颇具挑战。聚合物囊泡是由自组装嵌段共聚物构成的双层纳米囊泡,已被广泛用作细胞膜模拟物,用于膜蛋白的重构及人工细胞的构建。本综述重点介绍了聚合物囊泡在膜蛋白研究与药物发现中的应用趋势。首先,我们回顾了聚合物囊泡的合成与表征技术,以及将膜蛋白插入形成蛋白-聚合物囊泡(proteopolymersomes)的方法。随后,我们综述了在聚合物囊泡中重构的不同类型膜蛋白的结构与功能分析,包括膜运输蛋白、膜蛋白复合物和膜受体。接着,我们总结了影响重构效率及重构膜蛋白在结构功能研究中质量的因素。此外,我们还讨论了将蛋白-聚合物囊泡作为高通量筛选(HTS)平台用于药物发现、以识别膜蛋白调节剂的潜力。最后,我们展望了未来利用蛋白-聚合物囊泡推进膜蛋白研究与药物开发的建议与前景。

关键词:生物物理表征,药物发现,高通量筛选,插入,脂质体,纳米囊泡,聚合物囊泡,蛋白脂质体,蛋白-聚合物囊泡,重构状态 已发布 display-pdf 是 is-olf 否 is-manuscript 否 is-preprint 否 is-journal-matter 否 is-scanned 否 is-retracted 否 修订日期:2022年5月8日;收稿日期:2022年2月22日;接受日期:2022年5月10日;收录日期:2023年1月。

1. 引言 膜蛋白(MPs)占各种生物基因组编码蛋白质的20%–33%¹⁻³,是大多数药物的作用靶点靶点⁴⁻⁶。膜蛋白包括信号转导蛋白、通道蛋白、代谢物转运蛋白、细胞表面受体、酶和锚定蛋白。功能异常的膜蛋白与多种疾病相关,包括癌症、自身免疫性疾病和神经系统疾病⁷。因此,理解膜蛋白的结构与功能效应至关重要。目前,在蛋白质结构数据库(Protein Data Bank)超过181,969条蛋白质结构条目中,仅有6.5%为膜蛋白,且这些结构存储于不同数据库中³⁻⁹。其中,仅有不到2%在所有数据库中具有一致的高分辨率结构⁶⁻¹⁰。

膜蛋白研究匮乏的原因是多方面的。首先,膜蛋白通常不稳定,在蛋白质翻译过程中需要双层膜才能正确折叠。其次,尽管尝试过蛋白过表达,但难以获得高产量的稳定且功能正常的膜蛋白,因为膜蛋白通常数量较少,且易在细胞质中聚集⁶⁻¹¹。重要的是,由于与脂质膜相关的膜蛋白表面疏水性与溶剂分子亲水性之间的不兼容性,膜蛋白通常不溶于水溶液。因此,必须使用两亲性试剂从天然膜中提取膜蛋白,并维持其稳定的可溶形式。因此,需要开发模拟天然生物膜的合成膜平台,为膜蛋白提供两亲性环境,维持其结构与功能完整性,以用于体外蛋白质研究¹²⁻¹⁵。

传统的膜蛋白研究方法包括使用蛋白质锚定脂质双层膜和平面支撑脂质双层膜¹⁶⁻¹⁷。然而,这些系统存在局限性,如锚定分子与膜外结构域之间的不兼容、锚定分子占据区域不可及、插入膜蛋白的取向不可控,以及对其生物功能的限制¹⁶⁻¹⁷。因此,具有囊泡形态的细胞膜模拟物——即纳米囊泡——被越来越多地用于克服这些限制¹⁸。脂质体由天然无毒磷脂组成,而聚合物囊泡由两亲性嵌段共聚物形成¹⁹⁻²⁰。这两种纳米囊泡均与生物膜类似,适合作为膜蛋白的载体¹⁷⁻²²。这些纳米囊泡,或称小单层囊泡(SUV),尺寸为20–100 nm,与其他形态相比具有最小的界面面积和最高的构型熵,这使得它们在热力学上更有利于膜蛋白重构²⁰。它们比大单层囊泡(LUVs,>100 nm)和巨型单层囊泡(GUVs,>1 μm)具有更高的稳定性²⁰。此外,它们含有浓度梯度,这对形成孔道的通道膜蛋白功能起关键作用²³。

尽管脂质体已被广泛用于膜蛋白重构及相关结构与功能研究¹⁷,但其稳定性较低²²。为克服这一局限,聚合物囊泡因其优越的稳定性而被越来越多地用于膜蛋白研究²²⁻²⁴。含有重构膜蛋白的脂质体和聚合物囊泡分别称为蛋白脂质体(proteoliposomes)和蛋白-聚合物囊泡(proteopolymersomes)。除了寻找合适的膜支撑外,确保插入的膜蛋白以正确取向折叠并维持其生物功能,对于进一步表征这些膜蛋白至关重要¹⁴⁻¹⁵。因此,必须优化用于形成聚合物囊泡或杂化聚合物-脂质系统的化学成分²⁵⁻³⁰、膜蛋白生产方法以及重构过程中使用的参数¹⁷⁻³²。重构过程在决定重构效率、插入膜蛋白的质量以及用于研究这些膜蛋白的方法的分辨率与容量方面起着关键作用¹⁷⁻³¹。

在本文中,我们将综述聚合物囊泡在膜蛋白结构与功能研究中的应用,以及其在药物发现高通量筛选(HTS)中的转化应用(图1)。首先介绍聚合物囊泡的合成与表征,以及膜蛋白重构形成蛋白-聚合物囊泡的方法。随后总结蛋白-聚合物囊泡在研究通道蛋白、膜蛋白复合物和膜受体结构与功能中的应用。此外,我们提供了一份影响膜蛋白插入效率及插入膜蛋白质量的因素综合列表。最后,我们讨论了蛋白纳米囊泡在HTS中的可行性与当前应用。我们展望未来利用聚合物囊泡构建人工细胞的前景,并提出将蛋白-聚合物囊泡应用于药物发现流程的路线图与建议。

图1 聚合物囊泡作为膜蛋白研究与药物发现的平台。聚合物囊泡由嵌段共聚物构成,可模拟生物膜,用于重构或插入膜蛋白,包括通道蛋白、受体和蛋白复合物,形成蛋白-聚合物囊泡(中心)。蛋白-聚合物囊泡可用于研究膜蛋白的结构-功能关系,包括(a)通过表面等离子共振(SPR)表征受体-配体结合³³,(b)通过荧光染料渗漏实验检测通道运输功能,以及(c)通过核磁共振(NMR)解析膜蛋白结构。来源:图1c经参考文献34许可复制,版权所有2018,Springer Nature。(d)蛋白-聚合物囊泡还可用于药物发现的高通量筛选(HTS),以识别膜蛋白调节剂。示意图使用BioRender.com创建。

2. 聚合物囊泡的合成与表征 聚合物囊泡是球形纳米囊泡系统,聚合物壳层厚度为5–50 nm,由两亲性嵌段共聚物自组装形成³⁵⁻³⁸。聚合物囊泡膜提供物理屏障,将封装物质与外部生物环境隔离,同时由于存在浓度梯度,允许生物分子的可控释放或交换。聚合物囊泡与脂质体的一个主要区别在于化学可调性:脂质体的膜厚度限制在最多5 nm,而聚合物囊泡的膜厚度可达50 nm,具体取决于所用嵌段共聚物的类型²⁴。这表明聚合物囊泡可能比脂质体容纳更多更大的膜蛋白,尽管在膜蛋白插入过程中需考虑可能存在的疏水错配²⁴。由于组成嵌段聚合物分子量较高,且可通过紫外线照射形成交联结构³⁹⁻⁴⁰,聚合物囊泡通常具有增强的机械性能⁴¹⁻⁴²、更高的稳定性⁴³⁻⁴⁴、更低的解离速率、更低的渗透性⁴⁴和有限的泄漏⁴⁵,优于脂质体(图2a)²⁰⁻²²。此外,其致密的亲水性聚合物刷状冠层提高了抗降解能力,并延长了体内循环半衰期⁴⁸。

图2 聚合物囊泡的性质、形成机制与表征。(a)聚合物囊泡与脂质体囊泡性质的比较²⁰。(b)聚合物囊泡由嵌段共聚物自组装形成囊泡结构。用于形成聚合物囊泡的共聚物包括二嵌段共聚物(AB)和三嵌段共聚物(ABA、BAB和ABC)的不同组成。来源:经参考文献46许可复制,版权所有2012,Elsevier。(c)用于聚合物囊泡合成的二嵌段和三嵌段共聚物的化学成分列表。(d,e)两种不同提出的聚合物囊泡形成机制示意图:(d)首先由嵌段共聚物自组装形成球形胶束,然后进一步自组装成圆柱形或盘状胶束,这些胶束可卷绕形成囊泡结构;(e)由嵌段共聚物快速自组装形成小球形胶束,随后生长成更大的胶束。来源:图2d,e经参考文献44修改并许可复制,版权所有2011,Springer Nature。(f)由PBD-PEO共聚物形成的聚合物囊泡的冷冻透射电镜(cryo-TEM)图像。PBD的疏水核心为较暗区域。比例尺代表50 nm。来源:经参考文献47修改并许可复制,版权所有2002,ACS Publications。示意图使用BioRender.com创建。

2.1 用于聚合物囊泡合成的共聚物类型 二嵌段(AB)和三嵌段(ABA、BAB和ABC)共聚物³⁵⁻³⁸通常用于聚合物囊泡合成,其中A和C为亲水性嵌段,B为疏水性嵌段(图2b,c)⁴⁶⁻⁴⁷。通过控制聚合物嵌段长度和亲水-疏水嵌段比例,可调节聚合物囊泡的膜厚度、形态、刚性和渗透性²³⁻³⁷⁻⁴⁹⁻⁵⁰。

2.1.1 二嵌段共聚物 最常用的二嵌段聚合物是基于聚丁二烯-b-聚环氧乙烷(PBD-PEO)的⁴⁷⁻⁴⁹⁻⁵¹。其相对于其他二嵌段共聚物具有更高的流动性,适合用于研究膜受体⁵²⁻⁵³。聚苯乙烯-b-聚(异氰基丙氨酸[2-噻吩-3-乙基]酰胺)(PS-PIAT)二嵌段共聚物可自组装成固有渗透性的双层膜⁵⁴,已被用于克服聚合物囊泡渗透性较低的问题,从而测试更大通道或成孔蛋白的功能。其他用于膜蛋白研究的二嵌段聚合物包括聚乙二醇-b-聚三亚甲基碳酸酯(PEG-PTMC)⁵⁵和聚丙烯酸甲酯-b-聚乙二醇(PAA-PEG)⁵⁶。

2.1.2 三嵌段共聚物 聚(2-甲基噁唑啉)-聚(二甲基硅氧烷)-聚(2-甲基噁唑啉)(PMOXA-PDMS-PMOXA)⁵⁷⁻⁵⁸是用于膜蛋白研究的最常见三嵌段(ABA)聚合物。ABA聚合物可改变构象以适应膜蛋白长度,从而克服疏水错配,如在外膜孔蛋白F(OmpF)在PMOXA-PDMS-PMOXA中的重构⁵⁹,以及ATP合酶或细菌视紫红质(BR)在聚(2-乙基-2-噁唑啉)-b-聚(二甲基硅氧烷)-b-聚(2-乙基-2-噁唑啉)(PEtOz-PDMS-PEtOz)中的重构)中的重构⁶⁰⁻⁶²所示。为创建低渗透性的聚合物纳米隔室,聚异丁烯-聚乙二醇-聚异丁烯(PIB-PEG-PIB)(BAB)已被用于形成插入大肠杆菌(E. coli)外膜蛋白的聚合物囊泡⁶⁴。聚乳酸-聚乙二醇-聚乳酸(PLA–PEG–PLA)是另一种BAB型聚合物,已被用作纳米载体用于亲水性和疏水性药物的递送⁶⁵。

为模拟脂质组成的膜不对称性,聚环氧乙烷-b-聚(二甲基硅氧烷)-b-聚(2-甲基噁唑啉)(PEO-PDMS-PMOXA)(ABC)被使用⁶⁶⁻⁶⁷。ABC聚合物由于空间位阻可采取发夹或跨膜取向的混合物,适用于膜蛋白研究,因其可通过改变化学组成影响施加外部电场时插入整合蛋白的取向⁶⁸。最近,一种采用顺序微波辅助聚合方法一锅法合成新型ABC三嵌段三元共聚物——聚环氧乙烷-b-聚(2-(3-乙基庚基)-2-噁唑啉)-b-聚(2-乙基-2-噁唑啉)(PEO-PEHOx-PEtOz)的方法已有报道⁶⁹。所形成的聚合物囊泡的不对称性可通过改变PEO与PEtOz的比例进行调节,并可能用于膜蛋白的定向插入。在另一项研究中,聚乙二醇-聚(二异丙基氨基甲基丙烯酸乙酯)-b-聚(苯乙烯磺酸盐)(PEG-PDPA-PSS)已被用于蛋白视紫红质(PR)的定向插入⁷⁰。其他类型的ABC聚合物,包括聚环氧乙烷-b-聚己内酯-b-聚(2-甲基-2-噁唑啉)(PEO-PCL-PMOXA)⁷¹和PAA-PMA-PEG⁵⁶,也已成功形成聚合物囊泡,并可能为膜蛋白研究在新应用中提供新途径。

2.2 聚合物囊泡的合成 关于聚合物囊泡的形成,有两种不同的提出机制:(i)首先由嵌段共聚物自组装形成球形胶束,然后进一步自组装成圆柱形或盘状胶束,这些胶束可卷绕形成囊泡结构(图2d);(ii)由嵌段共聚物快速自组装形成小球形胶束,随后生长成更大的胶束和聚合物囊泡(图2e)⁷²。具体而言,聚合物囊泡可通过溶剂置换、聚合物薄膜再水化、固体再水化或电形成等技术由不同共聚物合成⁴³⁻⁶⁷⁻⁷³。在溶剂置换法中,将聚合物溶解在合适的有机溶剂中,逐滴加入水性缓冲液并剧烈搅拌形成乳液。虽然该方法简单快速,但聚合物囊泡尺寸的多分散性较高⁷⁴,且残留有机溶剂可能使大多数两亲性膜蛋白变性,导致重构效率低下⁷⁵。为克服有机溶剂的使用,已开发了聚合物再水化技术,即在再水化前先将聚合物溶液干燥以去除有机溶剂痕迹。使用聚合物薄膜再水化法生成的聚环氧乙烷-聚环氧乙烯(PEO-PEE)基聚合物囊泡尺寸较小,约100 nm,但粒径分布较宽⁴⁵。在固体再水化法中,将聚合物制成粉末形式后再在水性缓冲液中再水化,但需要更强且更长时间的搅拌以实现完全再水化⁴⁵。电形成是另一种常用于合成PMOXA-PDMS-PMOXA和PB-PEO聚合物囊泡的方法囊泡的方法⁷⁶⁻⁷⁷,但该方法产生的聚合物囊泡尺寸范围较大,为10–40 μm⁷⁸。其他技术包括3D软限制溶剂退火⁷⁹、用于生产PEG-PLA基聚合物囊泡的微流控液滴技术⁸⁰,以及凝胶辅助再水化法——将聚合物溶液铺展在脱水琼脂糖膜上,再在水性缓冲液中再水化⁸¹。

2.3 聚合物囊泡的表征 所形成的聚合物囊泡的流体动力学半径、粒径分布和形态可通过动态光散射(DLS)、静态光散射(SLS)、光学显微镜和透射电子显微镜(TEM)进行表征⁸²。高通量散射方法,如组合小角X射线散射(SAXS)或广角X射线散射(WAXS),可提供有关胶体尺寸结构特征的信息,包括膜双层厚度和内部结构⁸³。小角中子散射(SANS)技术可研究聚合物囊泡中聚合物共混物和共聚物的形态与热力学,以及聚合物囊泡结构⁸⁴。光学显微镜仅能分辨直径大于1 μm的聚合物囊泡⁸⁵,而高分辨率成像工具如TEM、冷冻透射电镜(cryo-TEM)和冷冻断裂冷冻扫描电镜(FF-Cryo-SEM)可提供约1000倍的分辨率提升和100倍的景深增加⁸⁵。特别是,cryo-TEM可避免电子显微镜样品制备过程中的干燥伪影,并能提供有关聚合物囊泡尺寸、形态和双层厚度的信息(图2f)⁸³。原子力显微镜(AFM)也可用于表征聚合物囊泡的机械性能⁸³。

3. 膜蛋白插入形成蛋白-聚合物囊泡的策略 将膜蛋白重构或插入聚合物囊泡已成为研究膜蛋白结构与功能的有力工具⁸⁶。为保持膜蛋白的结构完整性并赋予其生物功能,必须将其保存在与其天然环境相似的两亲性环境中,例如使用去垢剂防止变性。蛋白质-去垢剂-膜相互作用在膜蛋白插入中起关键作用,受蛋白质生产与纯化方法、所用去垢剂类型和用量以及聚合物囊泡的物理化学性质(包括流动性和柔性)的影响。膜蛋白可通过三种主要方法重构:(1)基于细胞的蛋白质生产和去垢剂介导的重构⁸⁷,(2)无细胞共翻译蛋白质生产和直接插入⁵³,以及(3)通过囊泡或支撑平面双层膜的去稳定化进行重构⁸⁸⁻⁹³。重构后,应进行透析、凝胶过滤或尺寸排阻色谱(SEC)、离心和bio-beads辅助程序等纯化步骤,以去除多余去垢剂和其他试剂,促进稳定蛋白-聚合物囊泡的形成。

3.1 基于细胞的蛋白质生产和去垢剂介导的重构 首先从质粒转化的细菌培养物中纯化重组膜蛋白,纯化的膜蛋白用去垢剂溶解并与过量聚合物通过自组装乳化,随后去除去垢剂(图3a)³²⁻⁹⁴。加入去垢剂有助于膜蛋白的溶解,并使其保持在天然环境中以促进膜蛋白折叠与稳定。在蛋白质重构后,需去除去垢剂以助于形成稳定囊泡,残留去垢剂也可能抑制蛋白质活性⁹⁴。通过此方法已将多种膜蛋白重构到聚合物囊泡中,常见的去垢剂去除方法包括透析⁹⁵、凝胶过滤或SEC⁸⁶⁻⁸⁷、离心⁵²或bio-beads辅助程序(表1)⁸⁶⁻⁸⁷。在透析法中,将膜蛋白与聚合物囊泡乳液在大量缓冲液中进行透析以去除多余去垢剂⁹⁵。对于凝胶过滤或SEC介导的去垢剂去除,将膜蛋白-聚合物囊泡溶液通过凝胶排阻柱,该柱在去垢剂之前分离并洗脱蛋白-聚合物囊泡。可使用从Sephadex G25到G200的不同尺寸柱子⁹⁴。该技术具有速度快的优点,但可能导致蛋白-聚合物囊泡的粒径分布变宽。采用离心法时,多余去垢剂及游离膜蛋白通过特定分子量截留的离心过滤筒过滤⁹⁰。对于bio-beads介导的去垢剂去除,使用微珠物理吸附并隔离多余去垢剂,随后可通过离心或过滤去除结合去垢剂的微珠⁹⁴。去垢剂去除方法的选择及其效率取决于膜蛋白重构过程中使用的去垢剂类型⁹⁴⁻¹¹⁴。具有高临界胶束浓度(CMC)的去垢剂,如胆酸盐和辛基葡萄糖苷,倾向于形成较小的胶束,更容易通过透析或SEC去除⁹⁴⁻¹¹⁴。具有较低CMC的去垢剂,如Triton-X 100,形成较大的胶束,不易通过透析或SEC去除,因此更常通过bio-beads辅助程序去除⁹⁴⁻¹¹⁴。基于细胞的蛋白质生产或膜蛋白过表达存在一些局限性,如产量低、细胞毒性、蛋白质聚集和错误折叠,这可能导致聚合物膜过度拥挤¹¹⁵。

图3 膜蛋白插入形成蛋白-聚合物囊泡的策略。(a)膜蛋白去垢剂介导重构到聚合物囊泡中。从天然膜中纯化膜蛋白,用去垢剂溶解并稳定。然后将膜蛋白溶液与溶解在有机溶剂中的聚合物混合,形成聚合物-蛋白质-去垢剂胶束混合物的乳液。当通过透析、凝胶过滤/SEC、离心或使用bio-beads等程序从胶束溶液中去除去垢剂时,膜蛋白被重构到囊泡中,形成蛋白-聚合物囊泡。来源:经参考文献87修改并许可复制,版权所有2002,SciELO。(b)通过无细胞蛋白质合成将膜蛋白自发插入聚合物囊泡形成蛋白-聚合物囊泡,方法是将编码目标蛋白的互补DNA和聚合物囊泡直接加入包括RNA聚合酶和核糖体的体外表达混合物中。来源:经参考文献53修改并许可复制,版权所有2012,John Wiley and Sons。(c-e)去垢剂对囊泡的去稳定化作用:(c)以NorA多药外排转运蛋白重构为例的脂质体⁸⁸,(d)以Cyt-bo3泛醌氧化酶重构为例的脂质与聚合物杂化囊泡⁸⁹,以及(e)以NADH:泛醌氧化还原酶(复合物I)取向增强和功能改善为例的聚合物囊泡⁹⁰。(f)通过bio-beads对支撑平面聚合物双层膜进行去稳定化以进行膜蛋白重构,以M1oK1的功能插入为例。来源:经参考文献91修改并许可复制,版权所有2014,Elsevier。示意图使用BioRender.com创建。

表1 基于蛋白-聚合物囊泡的膜蛋白研究列表 膜运输蛋白 嵌段共聚物 蛋白质生产 插入方法;纯化方法 (A)蛋白-聚合物囊泡表征